e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...
e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...
e xhibit ors list of exhibitors in alphabetical - ERA-EDTA Congress ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EXHIBITORS<br />
394<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
LIST OF EXHIBITORS<br />
IN ALPHABETICAL ORDER<br />
Companies are totally responsible for the description below<br />
Abbott .............................................Booth 2.03+2.90+2.88<br />
Abbott is a global, broad-based health care company<br />
devoted to the discovery, development, manufacture<br />
and market<strong>in</strong>g <strong>of</strong> pharmaceuticals and medical products,<br />
<strong>in</strong>clud<strong>in</strong>g nutritionals, devices and diagnostics.<br />
Our commitment to kidney care and kidney patients<br />
stretches back more than two decades and extends<br />
across our pharmaceutical, nutritional, diagnostic and<br />
vascular divisions. We produce and market a wide<br />
range <strong>of</strong> products that benefit kidney disease patients<br />
<strong>in</strong> more than 130 countries around the world today,<br />
and have an <strong>in</strong>dustry-lead<strong>in</strong>g pipel<strong>in</strong>e focused on<br />
br<strong>in</strong><strong>in</strong>g cont<strong>in</strong>ued <strong>in</strong>novation to patients tomorrow.<br />
Abbott <strong>in</strong>formation is available on the company’s<br />
websites at www.abbott.com<br />
Actual Way Medical Devices -<br />
Via Actual ........................................................ Booth 2.21<br />
We are ActualWay ® , a Portuguese manufacturer <strong>of</strong><br />
care treatment medical equipment such as Therapy,<br />
Sampl<strong>in</strong>g/Blood Donation, Gynaecological, Multifunctional<br />
Chairs, Couches and many accessories.<br />
We have been <strong>in</strong>creas<strong>in</strong>g our distribution all over the<br />
world thanks to big efforts <strong>in</strong> promot<strong>in</strong>g our products.<br />
Our sales strategy is based on build<strong>in</strong>g a long term relationship<br />
with all our partners provid<strong>in</strong>g quality and<br />
service. The best way to take care is to get our partners´<br />
and patients´ satisfaction meet<strong>in</strong>g their needs.<br />
We produce reliable, strong and comfortable products<br />
because we do care. Come and jo<strong>in</strong> us so that we can<br />
expand bus<strong>in</strong>ess together!<br />
www.actualway.pt<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Alam Medical ............................................... Booth 1.64A<br />
Alam Medical, a French company, develops, manufactures<br />
and markets high-tech medical products with<br />
particular focus on cardiovascular diagnosis with the<br />
Compliorr device. Complior AnalyseR measures aortic<br />
stiffness with the reference methodology: simultaneous<br />
carotid-femoral pulse wave velocity (PWV).<br />
Compliorr is the device used <strong>in</strong> most epidemiological<br />
studies which made PWV a recognized measurement<br />
<strong>of</strong> organ damage <strong>in</strong> the ESH guidel<strong>in</strong>es. The latest distance<br />
methodology and the <strong>in</strong>ternational PWV reference<br />
values are <strong>in</strong>cluded <strong>in</strong> Compliorr Analyse for a<br />
rapid and easy <strong>in</strong>terpretation <strong>of</strong> the results. With the<br />
Compliorr Analyse, it is possible to assess central pressure<br />
from a carotidogram. The measurement is handsfree<br />
and done dur<strong>in</strong>g the PWV measurement with no<br />
additional time. With Compliorr Analyse, you have<br />
the reference gold standard PWV and carotid central<br />
pressure analysis <strong>in</strong> a s<strong>in</strong>gle acquisition.<br />
www.complior.com<br />
Alere International ......................................... Booth 1.93<br />
By develop<strong>in</strong>g new capabilities <strong>in</strong> near-patient diagnosis,<br />
monitor<strong>in</strong>g and health management, Alere Inc.<br />
(formerly Inverness Medical Innovations, Inc.) enables<br />
<strong>in</strong>dividuals to take charge <strong>of</strong> improv<strong>in</strong>g their health<br />
and quality <strong>of</strong> life. Alere’s global lead<strong>in</strong>g products<br />
and services, as well as its new product development<br />
efforts, focus on <strong>in</strong>fectious disease, cardiology, oncology,<br />
drugs <strong>of</strong> abuse and women’s health. For more <strong>in</strong>formation<br />
about Alere, please visit at www.alere.com<br />
Alexion Pharma International ........ Booths 1.26+1.116<br />
Alexion Pharmaceuticals is a global biopharmaceutical<br />
company focused on serv<strong>in</strong>g patients with severe and<br />
ultra-rare disorders through the <strong>in</strong>novation, development<br />
and commercialization <strong>of</strong> life-transform<strong>in</strong>g therapeutic<br />
products. Alexion is the global leader <strong>in</strong> complement<br />
<strong>in</strong>hibition, and has developed and markets<br />
Soliris ® (eculizumab) as a treatment for patients with<br />
PNH and aHUS. Alexion is evaluat<strong>in</strong>g other potential<br />
<strong>in</strong>dications for Soliris and is develop<strong>in</strong>g four other<br />
highly <strong>in</strong>novative biotechnology product candidates.<br />
www.alxn.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
395<br />
EXHIBITORS
EXHIBITORS<br />
396<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X HPI OB IS T OE R S<br />
Allmed Medical ............................................. Booth 2.27<br />
Allmed Medical GmbH is a vertically <strong>in</strong>tegrated manufacturer,<br />
provid<strong>in</strong>g the latest world-class standards<br />
<strong>in</strong> dialysis products. Allmed’s lead<strong>in</strong>g dialyzer brand,<br />
Polypurer <strong>in</strong>corporates a new proprietary Polysulfone<br />
membrane, with outstand<strong>in</strong>g performances <strong>in</strong> both efficiency<br />
and biocompatibility aspects. The membrane<br />
is unique for its unprecedented Micro-Undulation<br />
Technology. Allmed and its partners are committed<br />
to <strong>of</strong>fer customised solutions to pr<strong>of</strong>essionals and patients<br />
<strong>in</strong> Hemodialysis. Capitaliz<strong>in</strong>g on its long experience<br />
<strong>in</strong> the field <strong>of</strong> hemodialysis, Allmed is able to give<br />
personalised service and assistance to its customers.<br />
www.allmedgrp.com<br />
Amgen Europe .................................................. Booth 2.48<br />
Amgen discovers, develops and delivers <strong>in</strong>novative<br />
human therapeutics. A biotechnology pioneer s<strong>in</strong>ce<br />
1980 and the orig<strong>in</strong>ator <strong>of</strong> recomb<strong>in</strong>ant ESAs, Amgen<br />
was one <strong>of</strong> the first companies to realize the new science’s<br />
promise by br<strong>in</strong>g<strong>in</strong>g novel medic<strong>in</strong>es from lab,<br />
to manufactur<strong>in</strong>g plant, to patient. Amgen therapeutics<br />
have changed the practice <strong>of</strong> medic<strong>in</strong>e, help<strong>in</strong>g millions<br />
<strong>of</strong> people <strong>in</strong> the fight aga<strong>in</strong>st cancer, kidney disease,<br />
rheumatoid arthritis and other serious illnesses. With<br />
a broad and deep pipel<strong>in</strong>e <strong>of</strong> potential new medic<strong>in</strong>es,<br />
Amgen rema<strong>in</strong>s committed to advanc<strong>in</strong>g<br />
science to dramatically improve people’s lives. June<br />
2011 marks 10 years s<strong>in</strong>ce the launch <strong>of</strong> Aranesp ® (darbepoet<strong>in</strong><br />
alfa) and 5 years s<strong>in</strong>ce the <strong>in</strong>troduction <strong>of</strong> the<br />
world’s firstgen. calcimimetic, Mimpara ® . We <strong>in</strong>vite<br />
you to come and celebrate with us on booth 2.02, level 2.<br />
www.amgen.com<br />
Arbor Research .............................................. Booth 1.G7<br />
Arbor Research is a not-for-pr<strong>of</strong>it research organization<br />
based <strong>in</strong> Ann Arbor, Michigan, USA, conduct<strong>in</strong>g<br />
large studies <strong>in</strong> epidemiology and public health. With<br />
particular expertise <strong>in</strong> biostatistical analysis, cl<strong>in</strong>ical<br />
practice, the management and <strong>in</strong>tegration <strong>of</strong> large data<br />
sets, economics, and public policy, Arbor Research engages<br />
<strong>in</strong> health outcomes research on chronic disease<br />
and end-stage organ failure, currently <strong>in</strong>clud<strong>in</strong>g the<br />
<strong>in</strong>ternational Dialysis Outcomes and Practice Patterns<br />
Study. www.dopps.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Asahi Kasei Medical Europe ............. Booths 1.42+1.47<br />
Asahi Kasei Medical is a world leader <strong>in</strong> research, development,<br />
and production <strong>of</strong> devices and systems for<br />
blood treatment and purification based on advanced<br />
membrane separation and adsorption technologies. It<br />
serves the global market with haemodialysis, therapeutic<br />
apheresis, and blood transfusion products. Information<br />
about Asahi’s membranes, adsorbents and<br />
full range <strong>of</strong> products can be found on our website at:<br />
www.asahikasei-medical.com<br />
Atcor Medical ............................................... Booth 1.G23<br />
AtCor Medical’s SphygmoCor ® systems, featured <strong>in</strong><br />
over 2000 published studies, are the global gold standard<br />
for non<strong>in</strong>vasive central blood pressure/arterial<br />
stiffness assessment. Major studies have found:<br />
-- Elevated central pressure is a superior <strong>in</strong>dependent<br />
predictor <strong>of</strong> CV risk<br />
-- 70% <strong>of</strong> patients with high normal blood pressure<br />
had central pressures equivalent with those <strong>of</strong> patients<br />
with Stage 1 Hypertension<br />
--Patients with central pulse pressure ≥ 50mmHg are<br />
at significantly higher risk for cardiovascular events.<br />
Visit us for a complementary central pressures assessment.<br />
www.atcormedical.com<br />
Atlantic Biomedical ....................................... Booth 2.04<br />
Atlantic Biomedical P. Ltd. is an overrid<strong>in</strong>g organization<br />
<strong>in</strong>corporated <strong>in</strong> the year 2008 by the jo<strong>in</strong>t efforts<br />
<strong>of</strong> Mr. Ravi Vazirani & Mr. Sunil Vazirani <strong>in</strong> the doma<strong>in</strong><br />
<strong>of</strong> dialysis related products and services. Atlantic<br />
Biomedical P. Ltd. is engaged <strong>in</strong> the manufactur<strong>in</strong>g <strong>of</strong><br />
medical equipments whereas Atlantic Pharmaceuticals<br />
(<strong>in</strong>corporated <strong>in</strong> the year 1987) is engaged <strong>in</strong> the<br />
manufactur<strong>in</strong>g and market<strong>in</strong>g <strong>of</strong> licensed drug products.<br />
Ours is an ISO 13485-2003 certified company and<br />
have dist<strong>in</strong>ction <strong>of</strong> be<strong>in</strong>g the first manufactures <strong>of</strong><br />
Dialyzer Reprocess<strong>in</strong>g Mach<strong>in</strong>e RENACLEAN ® , Cold<br />
Sterilant RENACLEAN ® , Hot Dis<strong>in</strong>fectant RENAS-<br />
TERIL ® , Acid Concentrate CITRACON ® , Calcium Acetate<br />
LOW-PHOS ® tablets <strong>in</strong> India. Apart from what<br />
we are one <strong>of</strong> the lead<strong>in</strong>g Dialysis Fluid Manufacturers<br />
<strong>in</strong> the country like Bicarbonate, Acetic, Na, K, Calcium<br />
Free & Citric Acid Concentrate.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
397<br />
EXHIBITORS
EXHIBITORS<br />
398<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Awak Technologies ....................................... Booth 1.68<br />
Awak is develop<strong>in</strong>g the world’s first wearable dialysis<br />
mach<strong>in</strong>e target<strong>in</strong>g ESRD patients. Our Vision is to create<br />
a new paradigm <strong>in</strong> renal dialysis. It is different from<br />
current dialysis mach<strong>in</strong>es <strong>in</strong> the market, as it provides<br />
patients with freedom dur<strong>in</strong>g their treatment. With<br />
Awak weigh<strong>in</strong>g only 1kg and the ability to regenerate<br />
spent dialysate, it now substitutes the major functions<br />
<strong>of</strong> a kidney by constantly remov<strong>in</strong>g tox<strong>in</strong>s and waste<br />
materials, and excessive fluid from the patient’s body.<br />
This new technology not only have and susta<strong>in</strong> ESRD<br />
patients, but also enhances their lives, br<strong>in</strong>g<strong>in</strong>g them<br />
comfort and convenience. www.awak.com<br />
B.Braun Avitum .............................................. Booth 2.12<br />
Always with Passion.<br />
B. Braun Avitum is a lead<strong>in</strong>g provider <strong>of</strong> dialysis care<br />
products. The B. Braun Avitum product range <strong>in</strong>cludes<br />
dialysis mach<strong>in</strong>es and dialysis consumables for<br />
chronic and acute dialysis as well as a comprehensive<br />
product portfolio for special blood cleans<strong>in</strong>g processes<br />
to treat conditions such as lipid metabolic disorders. B.<br />
Braun Avitum manufactures top quality dialysis mach<strong>in</strong>es,<br />
dialyzers (e.g. xevonta) and disposables.<br />
www.bbraun.com<br />
Ba<strong>in</strong> Medical Equipment ............................. Booth 1.22<br />
Ba<strong>in</strong> Medical Equipment (Guangzhou) Co., Ltd. was<br />
established <strong>in</strong> 2003 specialized <strong>in</strong> research<strong>in</strong>g, develop<strong>in</strong>g,<br />
manufactur<strong>in</strong>g and distribut<strong>in</strong>g <strong>of</strong> medical<br />
equipment and medical macromolecule products.<br />
We have strong technical strength, compris<strong>in</strong>g an experienced<br />
team with expertise and high technologies<br />
from Europe and Japan. Hav<strong>in</strong>g <strong>in</strong>troduced advanced<br />
manufactur<strong>in</strong>g and <strong>in</strong>spect<strong>in</strong>g facilities, we are able to<br />
perform dynamic monitor<strong>in</strong>g cover<strong>in</strong>g full process <strong>of</strong><br />
materials purchase, production and f<strong>in</strong>ished products.<br />
Presently Ba<strong>in</strong> specializes <strong>in</strong> manufactur<strong>in</strong>g and distribut<strong>in</strong>g<br />
hemodialyzer, tub<strong>in</strong>g sets for hemodialysis,<br />
disposable AV fistula needle sets, and tub<strong>in</strong>g disposables<br />
for hemodialysis, all with lead<strong>in</strong>g technologies <strong>in</strong><br />
the <strong>in</strong>dustry. ISO9001, ISO13485, CE and CCC certification<br />
passed. www.ba<strong>in</strong>medical.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Baxter Healthcare ........................................... Booth 2.39<br />
Baxter International Inc’s Renal franchise is a leader <strong>in</strong><br />
renal home therapies through its products for Peritoneal<br />
Dialysis (PD), provid<strong>in</strong>g PD solutions <strong>in</strong>clud<strong>in</strong>g<br />
Low Glucose, devices, related supplies and services<br />
to help end-stage kidney disease patients perform dialysis<br />
treatment <strong>in</strong> the home. Baxter also distributes<br />
products and provides support services for Cont<strong>in</strong>uous<br />
Renal Replacement Therapy (CRRT), an acute,<br />
hospital-based therapy, and distributes products for<br />
In-Center Hemodialysis (HD). Baxter, <strong>in</strong> partnership<br />
with DEKA Research and Development Corporation,<br />
is develop<strong>in</strong>g <strong>in</strong>novative technologies aimed at<br />
employ<strong>in</strong>g a compact design and convenient use for<br />
patients, such as a new automated PD cycler and High<br />
Dose HD technology platform. www.baxter.com<br />
Bellco .............................................................Hall Maillot<br />
Bellco, with over 40 years’ experience, operates worldwide<br />
<strong>of</strong>fer<strong>in</strong>g therapies and systems for blood purification<br />
<strong>in</strong> Dialysis, Intensive Care and Cardiology,<br />
with <strong>in</strong>creased focus on personalized treatments for<br />
critical patients. Bellco stands out for the Collaborative<br />
Research <strong>in</strong> the treatment <strong>of</strong> renal failure, multiple organ<br />
failure, sepsis and congestive heart failure, with<br />
the goal <strong>of</strong> shar<strong>in</strong>g know-how and <strong>in</strong>novation with the<br />
scientific and medical communities. Upon these premises,<br />
Bellco provides its contribution to the Collaborative<br />
Research Club. Biocompatibility, cardiovascular<br />
stability, nutritional state and clearance efficiency are<br />
the lead<strong>in</strong>g challenges for Bellco’s Therapeutic Dialysis:<br />
constant research and <strong>in</strong>novation for personalised<br />
solutions. Complex cl<strong>in</strong>ical conditions, such as those<br />
<strong>of</strong> patients <strong>in</strong> Intensive Care, undergo<strong>in</strong>g surgery,<br />
with multiple traumas, sepsis, multi-organ failure,<br />
cardiopathy, affected by immune pathologies and <strong>in</strong>toxication,<br />
require <strong>in</strong>tegrated therapeutic approaches<br />
capable <strong>of</strong> assur<strong>in</strong>g versatility, functionality and effectiveness.<br />
The Bellco’s all-embrac<strong>in</strong>g <strong>of</strong>fer for all these<br />
pathologies provides a completely new outlook on<br />
Acute patients. www.bellco.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
399<br />
EXHIBITORS
EXHIBITORS<br />
400<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
B<strong>in</strong>d<strong>in</strong>g Site ..................................................... Booth 1.05<br />
Visit stand 1.05 to learn more about polyclonal Freelite<br />
® serum free light cha<strong>in</strong> (FLC) measurement <strong>in</strong><br />
Acute Kidney Injury: “Clonal serum FLC can be measured<br />
with high sensitivity and specificity and used to<br />
rapidly screen for cast nephropathy. A susta<strong>in</strong>ed decrease<br />
<strong>in</strong> serum FLC levels with<strong>in</strong> 3 weeks <strong>of</strong> start<strong>in</strong>g<br />
treatment is associated with renal recovery”- Cockwell<br />
2010. Collect your copy <strong>of</strong> this paper and the Kidney<br />
<strong>in</strong> plasma cell dyscrasias book International Myeloma<br />
Work<strong>in</strong>g Group and NCCN ® guidel<strong>in</strong>es recommend<br />
use <strong>of</strong> serum free light cha<strong>in</strong> assays <strong>in</strong> the <strong>in</strong>itial diagnostic<br />
workup <strong>of</strong> Multiple Myeloma and related disorders.<br />
www.b<strong>in</strong>d<strong>in</strong>gsite.co.uk<br />
Bionic Mediz<strong>in</strong>technik ............................... Booth 1.103<br />
Bionic Mediz<strong>in</strong>technik with HQ <strong>in</strong> Friedrichsdorf near<br />
Frankfurt, Germany, is a specialised manufacturer <strong>of</strong><br />
products for dialysis s<strong>in</strong>ce 30 years. Our product range<br />
<strong>in</strong>cludes a large selection <strong>of</strong> dialysis fistula needles, dialysis<br />
catheters, therapy chairs and beds. Bionic dialysis<br />
fistula needles are lead<strong>in</strong>g <strong>in</strong> Europe and are sett<strong>in</strong>g<br />
new standards <strong>in</strong> quality and puncture characteristics.<br />
Bionic therapy chairs and beds are lead<strong>in</strong>g <strong>in</strong> performance<br />
and ergonomics. www.bionic-jms.com<br />
BioPorto Diagnostics .................................. Booth 1.G21<br />
The ability to diagnose acute kidney <strong>in</strong>jury (AKI) at an<br />
early time po<strong>in</strong>t is essential for improv<strong>in</strong>g the management<br />
and outcome <strong>of</strong> patients at risk <strong>of</strong> AKI. The novel<br />
biomarker NGAL has been shown to outperform current<br />
kidney status markers such as serum creat<strong>in</strong><strong>in</strong>e<br />
and cystat<strong>in</strong> C because it responds much earlier and<br />
shows a proportionate response to <strong>in</strong>jury. With The<br />
NGAL Test your hospital lab can measure NGAL<br />
<strong>in</strong> both plasma and ur<strong>in</strong>e samples on fully automated<br />
analyzers. www.bioporto.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Bodystat........................................................... Booth 1.G6<br />
BODYSTAT ® are established as one <strong>of</strong> the global leaders<br />
<strong>in</strong> body composition analysis us<strong>in</strong>g Bioelectrical<br />
Impedance Analysis (BIA) technology. Complex<br />
changes occur <strong>in</strong> body composition and fluid status<br />
dur<strong>in</strong>g illness, renal failure and haemodialysis. Bodystat’s<br />
Multi-Frequency BIA technology can be used to<br />
assist <strong>in</strong> achiev<strong>in</strong>g Dry Weight, quickly, conveniently,<br />
without significant tra<strong>in</strong><strong>in</strong>g or education.<br />
See validation paper: Calf Bioimpedance Ratio Improves<br />
Dry Weight Assessment and Blood Pressure<br />
Control <strong>in</strong> Hemodialysis Patients. (Yi-Lun Zhou et al)<br />
Am J Nephrol 2010;32:109-116.<br />
www.bodystat.com<br />
Covidien ........................................................... Booth 1.37<br />
Covidien Vascular Therapies delivers a broad range<br />
<strong>of</strong> <strong>in</strong>novative non-<strong>in</strong>vasive and endovascular devices<br />
for the treatment <strong>of</strong> vascular disease worldwide. Covidien<br />
currently <strong>of</strong>fers cl<strong>in</strong>ically proven solutions for<br />
the prevention and treatment <strong>of</strong> deep ve<strong>in</strong> thrombosis<br />
(DVT), chronic venous <strong>in</strong>sufficiency, dialysis access,<br />
peripheral vascular disease, and neurovascular disease.<br />
Covidien develops new technologies, products<br />
and programs focused on improved patient outcomes<br />
and safer, more efficient healthcare practices throughout<br />
the cont<strong>in</strong>uum <strong>of</strong> care, across the globe.<br />
www.covidien.com<br />
Cybernius Medical ......................................... Booth 1.16<br />
Cybernius Medical Ltd. is committed to the effective<br />
utilization <strong>of</strong> proven lead<strong>in</strong>g edge technology <strong>in</strong> the<br />
Health Care Industry. CML focuses its resources on<br />
the development, sale, deployment and support <strong>of</strong> the<br />
cyberREN ® Renal Patient Care Management System<br />
for Nephrology. cyberREN ® is a comprehensive Electronic<br />
Medical Record (EMR), Cl<strong>in</strong>ical Data Analysis,<br />
and Report<strong>in</strong>g System for Nephrology. cyberREN ® is<br />
marketed and serviced by a team <strong>of</strong> dedicated cl<strong>in</strong>icians<br />
and <strong>in</strong>formation technologists. Also Available:<br />
cyberREN OFFICE, (Nephrologist Private Practice<br />
System) and cyberFUNDS (Bill<strong>in</strong>g for Nephrology)<br />
To contact a representative <strong>in</strong> your area call:<br />
1.800.276.8128 or visit our website at<br />
www.cyberren.com - email: <strong>in</strong>fo@cyberren.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
401<br />
EXHIBITORS
EXHIBITORS<br />
402<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Culligan ............................................................ Booth 1.94<br />
Culligan International is one <strong>of</strong> the longest-established,<br />
best-known companies <strong>in</strong> the water treatment sector,<br />
founded <strong>in</strong> Chicago <strong>in</strong> 1936. Culligan is a worldwide<br />
organization whose mission is water quality improvement.<br />
We have an extensive licensee distribution system<br />
<strong>in</strong> over 100 countries. Culligan manufactures a<br />
complete l<strong>in</strong>e <strong>of</strong> systems for dr<strong>in</strong>k<strong>in</strong>g water, as well as<br />
for many demand<strong>in</strong>g <strong>in</strong>dustrial applications: ultrafiltration,<br />
electro-deionisation, pharmaceutical <strong>in</strong>dustry,<br />
haemodialysis, food and beverage <strong>in</strong>dustry, electronics<br />
<strong>in</strong>dustry, which requires the highest purity water<br />
possible. www.culligan.it<br />
Debiotech ......................................................... Booth 1.92<br />
Debiotech is a Swiss, <strong>in</strong>dependent, high-tech medical<br />
device development company founded <strong>in</strong> 1989.<br />
Its core competence lies <strong>in</strong> the identification <strong>of</strong> breakthrough<br />
technologies and their development to market<br />
approval. These devices are then licensed to major<br />
<strong>in</strong>ternational pharmaceutical and medical device companies.<br />
DialEase TM is the lightest and smallest APD<br />
Cycler ever conceived for Homecare Peritoneal Dialysis,<br />
with an <strong>in</strong>novative approach to <strong>of</strong>fer more Quality<br />
and Safety for Patients, with full remote control by<br />
Nephrologists, while simplify<strong>in</strong>g daily use and transportation.<br />
www.debiotech.com<br />
Diaverum ......................................................... Booth 2.19<br />
At Diaverum, our mission is to improve the quality <strong>of</strong><br />
life for renal patients by revitalis<strong>in</strong>g them both physically<br />
and emotionally. Be<strong>in</strong>g one <strong>of</strong> the world’s lead<strong>in</strong>g<br />
renal care providers, Diaverum <strong>of</strong>fers a ho<strong>list</strong>ic<br />
approach, from preventive and early stage renal care<br />
to all renal replacement therapies. As a product <strong>in</strong>dependent<br />
provider – the largest <strong>in</strong> Europe - we are able<br />
to focus soley on car<strong>in</strong>g for the <strong>in</strong>dividual needs <strong>of</strong><br />
our patients. Our experience <strong>in</strong> renal care dates back<br />
20 years, when the first dialysis cl<strong>in</strong>ic was established,<br />
previously under our former name Gambro Healthcare.<br />
Today, 6,800 employees care for more than 20,000<br />
patients <strong>in</strong> 17 countries <strong>in</strong> Europe, Lat<strong>in</strong> America,<br />
Middle East and Australia. The corporate <strong>of</strong>fice <strong>of</strong> Diaverum<br />
is located <strong>in</strong> Munich, Germany, the head <strong>of</strong>fice<br />
is <strong>in</strong> Lund, Sweden. For more <strong>in</strong>formation visit<br />
www.diaverum.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Dir<strong>in</strong>co .............................................................. Booth 1.32<br />
The Dir<strong>in</strong>co Group is a Dutch and Swiss based company,<br />
with <strong>in</strong>novations ma<strong>in</strong>ly <strong>in</strong> the field <strong>of</strong> vascular<br />
access, hemotology, oncology and nephrology. Citra-<br />
Lock - catheter lock solution, anti-clott<strong>in</strong>g and antimicrobial<br />
is one <strong>of</strong> the <strong>in</strong>novations from Dir<strong>in</strong>co. The<br />
products are <strong>in</strong> a vial or prefilled syr<strong>in</strong>ge and is based<br />
on tri-sodium citrate and can be safely used <strong>in</strong> all catheters!<br />
Please f<strong>in</strong>d the different catheter lock solutions<br />
like Citra-lock and CitraFlow by Dir<strong>in</strong>co on<br />
www.citra-lock.com<br />
Dustri Verlag ...................................................Booth 1.P1<br />
Cl<strong>in</strong>ical Nephrology – Dustri Verlag<br />
For almost 40 years, Cl<strong>in</strong>ical Nephrology, a Dustri-<br />
Verlag publication, has been one <strong>of</strong> the lead<strong>in</strong>g journals<br />
<strong>in</strong> its field. Under the edit<strong>ors</strong>hip <strong>of</strong> H.H. Malluche<br />
(Lex<strong>in</strong>gton, KT, USA) – supported by 18 Section Edit<strong>ors</strong><br />
– the editorial quality has improved significantly<br />
due to a remarkable <strong>in</strong>crease <strong>of</strong> manuscript submissions.<br />
Also ask for our special fellowship program.<br />
The book program <strong>of</strong> Dustri-Verlag was extended by<br />
“Seyffart’s Directory <strong>of</strong> Drug Dosage <strong>in</strong> Kidney Disease”<br />
<strong>in</strong> 2011<br />
www.cl<strong>in</strong>nephrol.com - www.dustri.com<br />
DV Care ............................................................ Booth 1.29<br />
DV Care., a wholly owned subsidiary <strong>of</strong> a United States<br />
based FORTUNE 500 ® company that is a lead<strong>in</strong>g provider<br />
<strong>of</strong> kidney care <strong>in</strong> the United States, deliver<strong>in</strong>g dialysis<br />
services to patients with chronic kidney failure and end<br />
stage renal disease. As <strong>of</strong> December 31, 2011, the organization<br />
operated or provided adm<strong>in</strong>istrative services<br />
at 1,809 dialysis facilities <strong>in</strong> the United States, serv<strong>in</strong>g<br />
approximately 142,000 patients. The company also operated<br />
11 outpatient dialysis centers located <strong>in</strong> three countries<br />
outside the United States. In l<strong>in</strong>e with the overall<br />
corporate mission, DV Care strives to improve patients’<br />
quality <strong>of</strong> life by <strong>in</strong>novat<strong>in</strong>g cl<strong>in</strong>ical care, and by <strong>of</strong>fer<strong>in</strong>g<br />
<strong>in</strong>tegrated treatment plans, personalized care teams<br />
and convenient health-management services. The organization<br />
also supports numerous programs dedicated<br />
to creat<strong>in</strong>g positive, susta<strong>in</strong>able change <strong>in</strong> communities<br />
around the world. The company’s leadership development<br />
<strong>in</strong>itiatives and social responsibility efforts have<br />
been recognized by Fortune, Modern Healthcare, Newsweek<br />
and WorldBlu. For <strong>in</strong>quiries dial +310 536 2478 or<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
403<br />
EXHIBITORS
EXHIBITORS<br />
404<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
send an email to global@davita.com.<br />
DWA ................................................................. Booth 2.81<br />
DWA - The Dialysis Water Specia<strong>list</strong>s<br />
DWA has specialised <strong>in</strong> <strong>in</strong>novative solutions for the<br />
supply <strong>of</strong> high purity water to dialysis centres - worldwide.<br />
DWA develops systems for production <strong>of</strong> ultrapure<br />
permeate and its distribution right to the dialysis<br />
mach<strong>in</strong>e. Our expertise <strong>in</strong> water treatment covers all<br />
aspects from the pre-treatment stages, through reverse<br />
osmosis, ultrafiltration and hot clean<strong>in</strong>g systems, right<br />
up to the supply connection through to the dialysis<br />
mach<strong>in</strong>e. In addition, DWA <strong>of</strong>fers systems for production<br />
and distribution <strong>of</strong> acid and bicarbonate concentrates.<br />
DWA is partner for dialysis centres - worldwide!<br />
www.dwa-onl<strong>in</strong>e.com<br />
E.D.P. La Traccia .......................................... Booth 1.G22<br />
Cooperativa Edp La Traccia is:<br />
- a Research Laboratory for the ICT and Robotic sect<strong>ors</strong>;<br />
- certified ISO 9001:2000 for the design, development,<br />
ma<strong>in</strong>tenance, assistance and sale <strong>of</strong> s<strong>of</strong>tware and<br />
hardware products; design<strong>in</strong>g and implementation<br />
<strong>of</strong> pr<strong>of</strong>essional tra<strong>in</strong><strong>in</strong>g projects;<br />
- certified ISO 27001 for specialized consultancy and<br />
expert technical assistance <strong>of</strong> s<strong>of</strong>tware and hardware<br />
products, management <strong>of</strong> LAN networks and<br />
<strong>in</strong>ternal <strong>in</strong>frastructures;<br />
- a recognized Tra<strong>in</strong><strong>in</strong>g Centre by the Basilicata Region.<br />
La Traccia, thanks to state-<strong>of</strong>-the-art technology and<br />
the large number <strong>of</strong> solutions <strong>in</strong> place with customers<br />
distributed all over Italy, is the Italian market leader<br />
for the supply <strong>of</strong>:<br />
- s<strong>of</strong>tware applications for Nephrology and Dialysis<br />
hospital wards (<strong>in</strong>stalled <strong>in</strong> over 210 Italian hospitals);<br />
- s<strong>of</strong>tware products for the Management <strong>of</strong> Organ<br />
Transplant Wait<strong>in</strong>g Lists (<strong>in</strong>stalled <strong>in</strong> 9 Italian Regions);<br />
- s<strong>of</strong>tware application to manage the Regional Dialysis<br />
and Organ Transplant Register (<strong>in</strong>stalled <strong>in</strong> 8 Italian<br />
Regions);<br />
- s<strong>of</strong>tware application for the management <strong>of</strong> “Register<br />
<strong>of</strong> Medical and Dental Surgeons (<strong>in</strong>stalled <strong>in</strong> 20<br />
Italian Prov<strong>in</strong>cial Orders);<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
The company has furthermore:<br />
- maturated significant experience <strong>in</strong> the computerization<br />
<strong>of</strong> Hospital Patient Records, with vertical <strong>in</strong>tegration<br />
for the various specializations;<br />
- carried out research projects: the most important<br />
<strong>of</strong> which was relative to Theme 7 <strong>of</strong> the National<br />
Research Project <strong>of</strong> Telemedic<strong>in</strong>e funded by the<br />
M.I.U.R. (Monitor<strong>in</strong>g <strong>of</strong> Dialysis and Per<strong>in</strong>atal Outpatients).<br />
www.latraccia.it<br />
EffeEmme ........................................................ Booth 2.44<br />
We have been produc<strong>in</strong>g bloodl<strong>in</strong>es and accessories<br />
for haemodialysis treatments for 30 years. Our company<br />
structure, always evolv<strong>in</strong>g, allows us to promptly<br />
react to the <strong>in</strong>creas<strong>in</strong>g requirements <strong>of</strong> the market. Our<br />
customers have confidence <strong>in</strong> us as a reliable partner<br />
with a track record <strong>of</strong> long last<strong>in</strong>g cooperation. On<br />
time delivery and service are our standard.<br />
www.effeemme.it<br />
EG Medical Systems ...................................... Booth 1.62<br />
EG-Medical Systems manufactures and supplies regionally<br />
a rich span <strong>of</strong> medical disposables and devices<br />
<strong>in</strong>clud<strong>in</strong>g Medical, Surgical & Dialysis disposables<br />
e.g. Blood L<strong>in</strong>es & Fistula Needles, Ur<strong>in</strong>e & Dra<strong>in</strong>age<br />
bags, Infusion & Transfusion sets, CVP, at top quality<br />
level s<strong>in</strong>ce year 2000. The company has been merited<br />
ISO 9001, ISO 13485, CE 0120 www.eggroup-eg.com<br />
Elsevier Masson ..............................................Booth 1.P4<br />
Elsevier Masson is the first French speak<strong>in</strong>g medical<br />
and paramedical publisher. Its three ma<strong>in</strong>s activities<br />
are the publish<strong>in</strong>g <strong>of</strong> books for <strong>in</strong>itial or cont<strong>in</strong>u<strong>in</strong>g<br />
education, <strong>of</strong> EMC treaties, and the publication<br />
<strong>of</strong> medical and paramedical journals. The university<br />
books, written by the best teachers, form all the pr<strong>of</strong>ession<br />
<strong>of</strong> health for two centuries. The books <strong>of</strong> cont<strong>in</strong>uous<br />
medical education, written by the best experts<br />
hospitalo-university and <strong>in</strong>tended for the pr<strong>of</strong>essionals<br />
<strong>of</strong> health, the general practitioner, the specia<strong>list</strong>s,<br />
the pharmacists, the dental surgeons, the veter<strong>in</strong>arians<br />
and <strong>in</strong> the all paramedical, <strong>in</strong>sure the permanent update<br />
<strong>of</strong> their practical knowledge. www.elsevier.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
405<br />
EXHIBITORS
EXHIBITORS<br />
406<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Emodial ............................................................ Booth 2.42<br />
Emodial Srl was established <strong>in</strong> 1982 <strong>in</strong> Ferrara, Italy,<br />
and s<strong>in</strong>ce that time has been operat<strong>in</strong>g <strong>in</strong> the field <strong>of</strong><br />
haemodialysis provid<strong>in</strong>g a complete range <strong>of</strong> products<br />
for dress<strong>in</strong>gs and becom<strong>in</strong>g one the lead<strong>in</strong>g companies<br />
<strong>in</strong> the field. Our products have been designed on the basis<br />
<strong>of</strong> the suggestions and co-operation <strong>of</strong>fered by various<br />
Dialysis Centres <strong>of</strong> relevant Care Units, which felt<br />
the need for new products suitable for the medications<br />
and absorption <strong>of</strong> wound exudates, to be used as an alternative<br />
to the traditional cotton or non-woven pads.<br />
Our ma<strong>in</strong> products can be referable to the follow<strong>in</strong>g<br />
typologies:<br />
-pads, plasters and bandages for fistula;<br />
-start-stop kits for haemodialysis, catheterism and<br />
peritoneal dialysis<br />
-devices for the disposal <strong>of</strong> used fistula needles;<br />
We have also recently developed a new range <strong>of</strong> patented<br />
products based on silver which helps to control<br />
the risk <strong>of</strong> <strong>in</strong>fections <strong>of</strong> the vascular access.<br />
www.emodial.it<br />
<strong>ERA</strong>-<strong>EDTA</strong> 2013 <strong>Congress</strong> Istanbul ........ Booth 1.G14<br />
The <strong>ERA</strong>-<strong>EDTA</strong> congress that will be held <strong>in</strong> Istanbul<br />
<strong>in</strong> 2013 (May 18-21) will be the 50 th annual congress <strong>of</strong><br />
this association. In order to mark this important anniversary<br />
the scientific programme will be richer than<br />
usual, with more pathways and more courses. The<br />
venue for this event will be the recently built Istanbul<br />
<strong>Congress</strong> Center, completed <strong>in</strong> September 2009 and<br />
situated <strong>in</strong> Harbiye, on a hilltop overlook<strong>in</strong>g the Bosphorus.<br />
Information will be available at the booth and<br />
<strong>in</strong> the website www.era-edta2013.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Etropal .............................................................. Booth 1.11<br />
Etropal is a company with over thirty years <strong>of</strong> experience<br />
<strong>in</strong> research, development and manufactur<strong>in</strong>g <strong>of</strong><br />
medical devices for s<strong>in</strong>gle use, meet<strong>in</strong>g all the requirements<br />
<strong>of</strong> a contemporary medic<strong>in</strong>e <strong>in</strong> this field. The<br />
company <strong>of</strong>fers an extensive product l<strong>in</strong>e that spans<br />
medical devices for haemodialysis-dialysers, blood<br />
l<strong>in</strong>es, fistula needles and other medical devices. The<br />
company operates a fully <strong>in</strong>tegrated ‘quality assurance<br />
system’ accord<strong>in</strong>g to ISO 9001 and ISO 13485.<br />
www.etropal.eu<br />
M E D I C A L E Q U I P M E N T<br />
Eurocl<strong>in</strong>ic ........................................................ Booth 1.G5<br />
Eurocl<strong>in</strong>ic SpA is a lead<strong>in</strong>g manufactur<strong>in</strong>g company<br />
specialized <strong>in</strong> the production <strong>of</strong> high-tech Medical<br />
Equipments presently distributed and appreciated <strong>in</strong><br />
more than 27 foreign countries ma<strong>in</strong>ly for the elegant<br />
design and the technical reliability. The cont<strong>in</strong>uous<br />
Research and Development activity is focused on<br />
state-<strong>of</strong>-art l<strong>in</strong>es <strong>of</strong> Units and Chairs for ENT, Podiatry,<br />
Gynaecology, Diagnostic & Imag<strong>in</strong>g fields. A new<br />
product for Dialysis/Oncology has been developed <strong>in</strong><br />
the last year thanks to a highly experienced team <strong>of</strong><br />
eng<strong>in</strong>eers. www.eurocl<strong>in</strong>ic.it<br />
FedAirg ............................................................ Booth 1.G9<br />
Federg is an <strong>in</strong>itiative aimed at establish<strong>in</strong>g a European<br />
federation <strong>of</strong> patients with renal genetic diseases<br />
(RGD). Federg will gather European associations devoted<br />
to RGD, thus provid<strong>in</strong>g enough voice and room<br />
to the smallest ones and given them more empowerment<br />
with<strong>in</strong> the European community: better <strong>in</strong>form,<br />
help and advocate, support research, better represent<br />
patients and foster the development <strong>of</strong> national associations.<br />
AIRG-France, a French association, focuss<strong>in</strong>g<br />
on Renal Genetic Diseases (RGD), has taken the <strong>in</strong>itiative<br />
<strong>of</strong> FEDERG and was promptly jo<strong>in</strong>ed by other<br />
AIRGs <strong>in</strong> Europe (Belgium, Switzerland and Spa<strong>in</strong>)<br />
and other RGD associations. It has received the support<br />
<strong>of</strong> <strong>ERA</strong>-<strong>EDTA</strong>, ESPN and Eurordis. The project<br />
will be developed <strong>in</strong> 2012, <strong>in</strong>formation can be found<br />
on the follow<strong>in</strong>g sites:<br />
www.federg2012.wordpress.com - www.airg-france.fr<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
407<br />
EXHIBITORS
EXHIBITORS<br />
408<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
French Society <strong>of</strong> Dialysis ......................... Booth 1.G11<br />
The Société de Francophone de Dialyse (SFD) is a<br />
French speak<strong>in</strong>g association <strong>of</strong> nephrologists founded<br />
<strong>in</strong> 1993, currently hav<strong>in</strong>g about 800 members throughout<br />
the French speak<strong>in</strong>g countries. The French speak<strong>in</strong>g<br />
Society <strong>of</strong> Dialysis aims to improve formation and<br />
collaborative work <strong>in</strong> dialysis through an annual Jo<strong>in</strong>t<br />
Meet<strong>in</strong>g with the Société de Néphrologie, and by organiz<strong>in</strong>g<br />
annually two or more specific CME courses <strong>in</strong><br />
collaboration with the Moroccan Society <strong>of</strong> Nephrology<br />
and the Tunisian Society <strong>of</strong> Nephrology. SFD contributes<br />
further to research on dialysis and end stage<br />
renal disease by fund<strong>in</strong>g cl<strong>in</strong>ical and fundamental research<br />
programmes. Publication media are the journal<br />
«Néphrologie & Thérapeutique», the e-learn<strong>in</strong>g website<br />
www.re<strong>in</strong>-eform.org and the society own website<br />
www.sfdial.org. Please visit the booth to learn more<br />
on SFD and jo<strong>in</strong> us.<br />
French Society <strong>of</strong> Nephrology .................... Booth 1.G8<br />
The Société de Néphrologie (SN) is a French speak<strong>in</strong>g<br />
association <strong>of</strong> nephrologists founded <strong>in</strong> 1961, currently<br />
hav<strong>in</strong>g about 1500 members. Its publication is<br />
Néphrologie & Thérapeutique. SN contributes to the<br />
dissem<strong>in</strong>ation <strong>of</strong> knowledge by its annual Jo<strong>in</strong>t Meet<strong>in</strong>g<br />
with the Société Francophone de Dialyse, and by<br />
organiz<strong>in</strong>g annually a specific CME course. SN contributes<br />
to research <strong>in</strong> nephrology directly by fund<strong>in</strong>g<br />
research projects both for laboratories and <strong>in</strong>dividual<br />
researchers as post-doctoral tra<strong>in</strong><strong>in</strong>gs. Visit the booth<br />
to learn about the next annual Jo<strong>in</strong>t Meet<strong>in</strong>g: Geneva,<br />
October 2-5, 2012. More <strong>in</strong>formation at:<br />
www.soc-nephrologie.org<br />
Fresenius Kabi ................................................ Booth 2.68<br />
Fresenius Kabi is dedicated to the therapy and care <strong>of</strong><br />
critically and chronically ill patients <strong>in</strong>side and outside<br />
the hospital by provid<strong>in</strong>g <strong>in</strong>travenously adm<strong>in</strong>istered<br />
drugs, <strong>in</strong>fusion therapies, cl<strong>in</strong>ical nutrition and related<br />
medical devices. The company applies its long-stand<strong>in</strong>g<br />
expertise <strong>in</strong> pharmaceuticals and medical devices<br />
to support cl<strong>in</strong>ical staff and care pr<strong>of</strong>essionals <strong>in</strong> the<br />
best therapy <strong>of</strong> patients. For more <strong>in</strong>formation about<br />
Fresenius Kabi, visit the company’s Web site at<br />
www.fresenius-kabi.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Fresenius Medical Care ................................. Booth 2.68<br />
Fresenius Medical Care is the world’s largest <strong>in</strong>tegrated<br />
provider <strong>of</strong> products and services for <strong>in</strong>dividuals<br />
undergo<strong>in</strong>g dialysis because <strong>of</strong> chronic kidney failure,<br />
a condition that affects more than 2.1 million <strong>in</strong>dividuals<br />
worldwide. Through its network <strong>of</strong> more than<br />
2,890 dialysis cl<strong>in</strong>ics <strong>in</strong> North America, Europe, Lat<strong>in</strong><br />
America, Asia-Pacific and Africa, Fresenius Medical<br />
Care provides dialysis treatment to more than 233,100<br />
patients around the globe. Fresenius Medical Care is<br />
also the world’s lead<strong>in</strong>g provider <strong>of</strong> dialysis products<br />
such as hemodialysis mach<strong>in</strong>es, dialyzers and related<br />
disposable products. With the new bus<strong>in</strong>ess unit Renal<br />
Pharma Fresenius Medical Care is now complement<strong>in</strong>g<br />
its lead<strong>in</strong>g dialysis technologies, products and<br />
services with renal pharmaceuticals. We will cont<strong>in</strong>uously<br />
build up and provide a comprehensive range <strong>of</strong><br />
drugs and drive their <strong>in</strong>tegration <strong>in</strong>to <strong>in</strong>novative treatment<br />
platforms to achieve improved therapeutic outcomes<br />
<strong>in</strong> dialysis patients. www.fmc-ag.de<br />
Gambro ............................................................ Booth 2.46<br />
Gambro has been pioneer<strong>in</strong>g solutions for patients <strong>in</strong><br />
Chronic and Acute Therapies for more than 47 years.<br />
With you and your patients as our <strong>in</strong>spiration, we are<br />
constantly seek<strong>in</strong>g ways to advance the science <strong>of</strong> dialysis.<br />
The result is <strong>in</strong>novative products & therapies<br />
that will support your success. Gambro - Your home <strong>of</strong><br />
INNOVATION - You <strong>in</strong>spire, We <strong>in</strong>novate.<br />
www.gambro.com<br />
Gardhen Bilance ...........................................Booth 1.98C<br />
Gardhen bilance is a company presents <strong>in</strong> most parts<br />
<strong>of</strong> the world thanks to its exclusive distribut<strong>ors</strong> and to<br />
high quality <strong>of</strong> the products. The beds and chairs with<br />
or without scales are presents <strong>in</strong> all privates dialysis<br />
centers and dialysis hospital departments. Gardhen bilance<br />
manufactures medical devices and weigh<strong>in</strong>g systems<br />
<strong>in</strong> conformity to ISO 9001:2008, ISO 13485:2003,<br />
93/42/CEE. Design, comfort, robust construction is<br />
our mission www.gardhenbilance.it<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
409<br />
EXHIBITORS
EXHIBITORS<br />
410<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
HemoSapiens ............................................... Booth 1.G24<br />
Hemo Sapiens ® Inc is a high-tech medical company<br />
specialized <strong>in</strong> the development <strong>of</strong> non-<strong>in</strong>vasive medical<br />
devices designed for the real-time assessment,<br />
monitor<strong>in</strong>g and management <strong>of</strong> complete hemodynamics.<br />
Hemo Sapiens ® ® flagship product is Hotman ®<br />
- a PC-based system for automatic, non<strong>in</strong>vasive and<br />
hands-free acquisition <strong>of</strong> a patient’s blood flow and<br />
left-ventricular parameters us<strong>in</strong>g Company’s proprietary<br />
very-low current TEB (Thoracic Electrical Bioimpedance)<br />
provid<strong>in</strong>g the unique Integrated Hemodynamic<br />
Management solution.<br />
www.hemosapiens.net<br />
Herco Wassertechnik ..................................... Booth 2.64<br />
Herco developed and <strong>of</strong>fers complete water treatment<br />
solutions for dialysis applications. Products are: Water<br />
s<strong>of</strong>teners, filters, reverse osmosis, r<strong>in</strong>g ma<strong>in</strong>, bed<br />
head media panels, central concentrate distribution.<br />
Reverse osmosis units for haemodialysis purposes accord<strong>in</strong>g<br />
to MDD, TÜV approved. www.herco-wt.de<br />
Hospira UK ...................................................... Booth 2.83<br />
Hospira is a global speciality pharmaceutical and<br />
medication delivery company dedicated to Advanc<strong>in</strong>g<br />
Wellness. As a world expert <strong>in</strong> speciality generic<br />
<strong>in</strong>jectable pharmaceuticals, Hospira <strong>of</strong>fers one <strong>of</strong> the<br />
broadest portfolios <strong>of</strong> generic acute-care and oncology<br />
<strong>in</strong>jectables, as well as <strong>in</strong>tegrated <strong>in</strong>fusion therapy<br />
and medication management solutions. Through its<br />
products, Hospira helps improve the safety, cost and<br />
productivity <strong>of</strong> patient care. The company is headquartered<br />
<strong>in</strong> Lake Forest, Ill<strong>in</strong>ois, United States and<br />
has more than 14,000 employees. The head <strong>of</strong>fice for<br />
Hospira <strong>in</strong> Europe, Middle East and Africa is <strong>in</strong> Royal<br />
Leam<strong>in</strong>gton Spa, UK. Learn more about Hospira at<br />
www.hospira.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
IFKF - International Federation<br />
<strong>of</strong> Kidney Foundation .................................. Booth 1.G4<br />
Improv<strong>in</strong>g Kidney Health Worldwide<br />
Our Long Term Commitment:<br />
Improvement <strong>in</strong> prevention, quality <strong>of</strong> life and health<br />
for all people with or at risk <strong>of</strong> kidney disease, regardless<br />
<strong>of</strong> race, color, creed, gender, sexual orientation or<br />
social class.<br />
Our Mission:<br />
To foster creation, growth, and <strong>in</strong>ternational collaboration<br />
between local kidney foundations and to enable<br />
and help empower member organizations to atta<strong>in</strong> our<br />
goals. To represent at the <strong>in</strong>ternational level the needs<br />
<strong>of</strong> people with, or at risk <strong>of</strong> kidney disease. Our worldwide<br />
community <strong>of</strong> kidney foundations constitutes a<br />
unique and potent force to br<strong>in</strong>g a global <strong>in</strong>strument<br />
for the prevention, detection and treatment <strong>of</strong> kidney<br />
disease.<br />
Our Tools:<br />
Annual meet<strong>in</strong>g, regional meet<strong>in</strong>gs, Kidney Foundations<br />
Partnership Program KFPP, educational programs<br />
and sem<strong>in</strong>ars for health care workers on nutrition<br />
and other topics. SeeKD ® program for detection<br />
and prevention <strong>of</strong> CKD. Joel D Kopple Award for<br />
outstand<strong>in</strong>g performance, IFKF Innovation Challenge<br />
for <strong>in</strong>novative ideas for compliance with medic<strong>in</strong>e use.<br />
World Kidney Day, <strong>in</strong> cooperation with ISN.<br />
www.ikfk.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
411<br />
EXHIBITORS
EXHIBITORS<br />
412<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Immundiagnostik ....................................... Booth 1.G19<br />
Clos<strong>in</strong>g the Gaps <strong>in</strong> Laboratory Diagnostics<br />
Immundiagnostik AG, founded <strong>in</strong> 1986, is a globally<br />
operat<strong>in</strong>g diagnostics company represented <strong>in</strong> over 30<br />
countries. We focus on the development and production<br />
<strong>of</strong> <strong>in</strong>novative immunoassays (ELISA, EIA) and<br />
other analytical detection methods (e.g. HPLC, LC-<br />
MS/MS and PCR) for medical rout<strong>in</strong>e and research.<br />
Our mission is to provide effective tools for prevention,<br />
differential diagnosis and therapy monitor<strong>in</strong>g <strong>in</strong><br />
the areas <strong>of</strong> gastroenterology, cardiovascular diseases,<br />
disorders <strong>of</strong> the skeletal system and oxidative stress.<br />
The product portfolio is completed by a broad range<br />
<strong>of</strong> antibodies and antigens. Our bus<strong>in</strong>ess relations <strong>in</strong>clude<br />
contract analyses for diagnostic laboratories and<br />
academic research <strong>in</strong>stitutions, esp. <strong>in</strong> context with<br />
cl<strong>in</strong>ical trials. Multiple cooperations with the pharmaceutical<br />
<strong>in</strong>dustry and a tight network with scientific<br />
organisations are the basis for a successful product<br />
development. Secur<strong>in</strong>g progress: Our comprehensive<br />
range <strong>of</strong> products is cont<strong>in</strong>uously refuelled by a rich<br />
pipel<strong>in</strong>e <strong>of</strong> proprietary developments. With a headcount<br />
<strong>of</strong> more than 60 employees, Immundiagnostik’s<br />
headquarter is located <strong>in</strong> Bensheim, south-western<br />
Germany. www.immundiagnostik.com<br />
Infomed ............................................................ Booth 1.45<br />
With 20 years <strong>of</strong> experiences around the world, Infomed<br />
has comforted its leadership as a provider <strong>of</strong><br />
extracorporeal blood purification devices <strong>of</strong>fer<strong>in</strong>g<br />
complete solutions with many advanced medical<br />
treatments such as: Cont<strong>in</strong>uous hem<strong>of</strong>iltration and hemodiafiltration,<br />
plasma exchange, cascade filtration,<br />
double filtration plasmapheresis (DFPP), blood and<br />
plasma perfusion and CPFA (Coupled Plasma Filtration<br />
Adsorption). Infomed provides a complete range<br />
<strong>of</strong> mach<strong>in</strong>es and all associated disposables such as<br />
pre-assembled kits, filters and adsorption cartridges.<br />
www.<strong>in</strong>fomed.biz<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Innovative Blood Purification...................... Booth 1.50<br />
We are an <strong>in</strong>tegrated provider <strong>of</strong> hemodialysis medical<br />
disposables products, such as Dialyzers, Bloodl<strong>in</strong>e<br />
Sets & AV Fistula Needle Sets and Dialysate Solution,<br />
for <strong>in</strong>dividuals undergo<strong>in</strong>g dialysis due to chronic<br />
kidney failure. We manufacture and distribute our<br />
hemodialysis medical disposables to dialysis cl<strong>in</strong>ics<br />
all over Eastern Europe, Middle East and Asia Pacific.<br />
Through our jo<strong>in</strong>tly-owned German subsidiary, International<br />
Dialysers Technologies GmbH (“IDT”) that<br />
own and manage a dialyzer assembly plant <strong>in</strong> Germany,<br />
we were able to develop our Dialyzer under our<br />
own brand name “Innovative”, we also manufactured<br />
our products via our OEM Partners. All our products<br />
are certified with CE and ISO 13485.<br />
www.<strong>in</strong>novative-bp.com<br />
Intermedt Mediz<strong>in</strong> & Technik .................... Booth 1.97<br />
Intermedt was founded <strong>in</strong> 1997 and is a specia<strong>list</strong> for<br />
dialysis concentrate production systems.<br />
The fully automatic dry concentrate system ECOMix<br />
<strong>in</strong> comb<strong>in</strong>ation with ECOCart allows the production<br />
<strong>of</strong> concentrate <strong>in</strong> your own dialysis center. We<br />
don’t transport any Water only the dry salts <strong>in</strong> large<br />
cartridges. The “ECOCart” is a reusable cartridge and<br />
conta<strong>in</strong>s all raw materials <strong>in</strong> dry form for the production<br />
<strong>of</strong> 750l acid concentrate. www.<strong>in</strong>termedt.de<br />
ISN International Society <strong>of</strong> Nephrology Booth 1.G3<br />
The International Society <strong>of</strong> Nephrology (ISN) is a<br />
global not-for-pr<strong>of</strong>it society dedicated to its philanthropic<br />
mission <strong>of</strong> advanc<strong>in</strong>g the diagnosis, treatment,<br />
and prevention <strong>of</strong> kidney diseases <strong>in</strong> the develop<strong>in</strong>g<br />
and developed world. S<strong>in</strong>ce its foundation <strong>in</strong> 1960,<br />
ISN has pursued the worldwide advancement <strong>of</strong> education,<br />
science and patient care <strong>in</strong> nephrology. The<br />
Society represents a wide <strong>in</strong>ternational network and<br />
provides an efficient platform for timely scientific exchange,<br />
debate and dissem<strong>in</strong>ation between healthcare<br />
pr<strong>of</strong>essionals around the world. ISN has over 9,000<br />
pr<strong>of</strong>essional members from more than 126 countries.<br />
In addition, ISN closely collaborates with over 70 national<br />
and regional nephrology societies around the<br />
world, represent<strong>in</strong>g about 20,000 pr<strong>of</strong>essionals.<br />
www.theisn.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
413<br />
EXHIBITORS
EXHIBITORS<br />
414<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Janssen .............................................................. Booth 2.37<br />
Janssen Pharmaceutical Companies <strong>of</strong> Johnson &<br />
Johnson are dedicated to address<strong>in</strong>g and solv<strong>in</strong>g the<br />
most important unmet medical needs <strong>of</strong> our time, <strong>in</strong>clud<strong>in</strong>g<br />
oncology (e.g. multiple myeloma and prostate<br />
cancer), immunology (e.g. psoriasis), neuroscience<br />
(e.g. schizophrenia, dementia and pa<strong>in</strong>), <strong>in</strong>fectious<br />
disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis),<br />
and cardiovascular and metabolic diseases (e.g.<br />
diabetes). Driven by our commitment to patients, we<br />
develop susta<strong>in</strong>able, <strong>in</strong>tegrated healthcare solutions<br />
by work<strong>in</strong>g side-by-side with healthcare stakeholders,<br />
based on partnerships <strong>of</strong> trust and transparency. More<br />
<strong>in</strong>formation can be found at www.janssen-emea.com<br />
JiHua Medical Apparatus and Instruments .Booth 1.G17<br />
Jihua Medical Apparatus and Instruments Co.,LTD<br />
GuangZhou (Jihua Company), established <strong>in</strong> 2000. We<br />
are specialized to research, produce and sell hemodialysis<br />
equipment and some relative blood purification<br />
devices such as electric dialysis chair, RO water<br />
unit, dialyzer reprocess<strong>in</strong>g mach<strong>in</strong>e, hemoperfusion<br />
mach<strong>in</strong>e, blood pump, dialysate powder stirr<strong>in</strong>g mach<strong>in</strong>e<br />
ect. Our dialysis equipments have ga<strong>in</strong>ed the CE<br />
mark and company are certified with ISO 9001&ISO<br />
13485 <strong>in</strong> 2007. So far, Jihua products are sell<strong>in</strong>g <strong>in</strong> the<br />
whole prov<strong>in</strong>ces <strong>in</strong> ch<strong>in</strong>a and successfully exported<br />
to more than 60 countries <strong>in</strong> Asia, South America, Europe<br />
and Africa countries. Our vision is to contribute<br />
to the growth <strong>of</strong> <strong>in</strong>ternational blood purification career<br />
and to be the leadership on nephrology with the most<br />
pr<strong>of</strong>essional and susta<strong>in</strong>able development ability and<br />
outstand<strong>in</strong>g corporate culture. www.ji-hua.com<br />
Jol<strong>in</strong>e ................................................................. Booth 1.34<br />
Jol<strong>in</strong>e GmbH & Co. KG is an <strong>in</strong>ternationally operat<strong>in</strong>g<br />
company <strong>in</strong> southern Germany with a strong focus<br />
on quality standards and <strong>in</strong>novative, medical technologies.<br />
S<strong>in</strong>ce our foundation <strong>in</strong> 1999 it has been our<br />
<strong>in</strong>tent to develop and produce high-quality products<br />
<strong>in</strong> the field <strong>of</strong> Vascular Access. All our FlowFamily-<br />
Products are CE marked and exclusively “Made <strong>in</strong><br />
Germany”. www.jol<strong>in</strong>e.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Karger ...............................................................Booth 1.P6<br />
S. Karger Medical Publishers is a publish<strong>in</strong>g house<br />
whose publications <strong>in</strong> the field <strong>of</strong> nephrology <strong>in</strong>clude<br />
6 scientific journals, e.g. ‘Nephron’, and the renowned<br />
book series ‘Contributions to Nephrology’. New releases<br />
presented <strong>in</strong>clude the titles Hepatitis C <strong>in</strong> Renal<br />
Disease, Hemodialysis and Transplantation’, ‘On-L<strong>in</strong>e<br />
Hemodiafiltration: The Journey and the Vision’ and<br />
‘Controversies <strong>in</strong> Acute Kidney Injury’. Publications<br />
are accessible onl<strong>in</strong>e, with full-text search <strong>of</strong> articles,<br />
pay-per-view options and many other services. Founded<br />
122 years ago, this Swiss-based family-owned publish<strong>in</strong>g<br />
house comb<strong>in</strong>es highly sophisticated production<br />
technology with customized services for its auth<strong>ors</strong>,<br />
edit<strong>ors</strong> and readers.<br />
www.karger.com/nephrology<br />
Kawasumi ........................................................ Booth 2.05<br />
S<strong>in</strong>ce 1957, Kawasumi Laboratories has been provid<strong>in</strong>g<br />
nephrologists worldwide dialyzers, blood tub<strong>in</strong>g<br />
l<strong>in</strong>es, and AV fistula sets. We are renowned for our<br />
consistently high quality. Kawasumi is a lead<strong>in</strong>g supplier<br />
<strong>of</strong> advanced dialyzers. The RENAK PS dialyzer<br />
will delight you with its high performance. Blood<br />
tub<strong>in</strong>g l<strong>in</strong>es and AV fistula sets are among the best<br />
known and most trusted <strong>in</strong> the world. Kawasumi also<br />
provides a wide variety <strong>of</strong> therapeutic plasmapheresis<br />
products. Visit the Kawasumi booth and see how we<br />
can help you provide excellent therapy!<br />
www.kawasumi.jp<br />
Kimal ................................................................ Booth 1.01<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
415<br />
EXHIBITORS
EXHIBITORS<br />
416<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Labor Limbach ............................................. Booth 1.G20<br />
Limbach Laboratory is the market leader <strong>in</strong> medical<br />
laboratory test<strong>in</strong>g <strong>in</strong> Germany as well as the largest<br />
provider <strong>of</strong> diagnostic services to nephrology<br />
departments, dialysis units and nephrologists <strong>in</strong> private<br />
practices. It was founded 1979 <strong>in</strong> Heidelberg by<br />
Dr.med. Hans-Jakob Limbach. A central focus <strong>of</strong> its<br />
activity was the determ<strong>in</strong>ation <strong>of</strong> parathyroid hormone<br />
and other special hormone test<strong>in</strong>g. Today, Limbach<br />
Laboratories Group covers all diagnostic fields <strong>of</strong><br />
laboratory medic<strong>in</strong>e with<strong>in</strong> 29 affiliated laboratories<br />
countrywide. Furthermore, it has built up a network<br />
<strong>of</strong> laboratory services throughout Europe. Last but not<br />
least, Limbach Laboratory has an active R&D program<br />
<strong>in</strong> the field <strong>of</strong> test development, particularly for markers<br />
<strong>of</strong> bone metabolism. www.labor-limbach.de<br />
Lauer ................................................................. Booth 2.12<br />
LMW/Aquaboss ® stands for <strong>in</strong>novation, quality and<br />
cost efficiency. S<strong>in</strong>ce 1989 Lauer is develop<strong>in</strong>g, manufactur<strong>in</strong>g<br />
and market<strong>in</strong>g RO systems, accessory equipment<br />
for dead space free supply <strong>of</strong> purified water and<br />
other liquid media used <strong>in</strong> dialysis. Dur<strong>in</strong>g the years<br />
Lauer has <strong>in</strong>troduced several patented technologies<br />
<strong>in</strong>renal market, e.g. impulse backwash<strong>in</strong>g and secondary<br />
r<strong>in</strong>g ma<strong>in</strong>s.<br />
www.aquaboss.com<br />
Likamed ........................................................... Booth 2.66<br />
We are an expert for therapy and treatment chairs<br />
and beds <strong>in</strong> the medical field and we are more than 30<br />
years successful <strong>in</strong> the market. Our long last<strong>in</strong>g experience<br />
und strict quality check, guarantee that the label<br />
“Made by Likamed” stands always for highest quality.<br />
Our products and our company are certificated for<br />
DIN EN ISO 13485. www.likamed.de<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Medcomp ......................................................... Booth 1.71<br />
Medcomp, well known for its wide range <strong>of</strong> cuffed<br />
and uncuffed venous access catheters will be <strong>of</strong>fer<strong>in</strong>g<br />
new <strong>in</strong>formation on:<br />
1. Videos on new dialysis catheter implantation technique<br />
2. Catheter Lock<strong>in</strong>g Solutions<br />
3. Long Term Dialysis Catheters<br />
4. Acute Access Blood Purification Catheters<br />
www.medcompnet.com<br />
Medica Italia ................................................. Booth 1.100<br />
Mdica S.p.A. is located <strong>in</strong>side the biomedical district <strong>of</strong><br />
Mirandola near Modena Italy. Medica was established<br />
<strong>in</strong> 1985, and s<strong>in</strong>ce then it has been operat<strong>in</strong>g <strong>in</strong> the<br />
manufactur<strong>in</strong>g and sales <strong>of</strong> medical devices specifically<br />
<strong>in</strong> the field <strong>of</strong> blood purification and recently also<br />
<strong>in</strong> water purification, provid<strong>in</strong>g an extensive range <strong>of</strong><br />
products. Blood l<strong>in</strong>es, Dialysers, Electro medical mach<strong>in</strong>es<br />
and associated disposables and Infusion disposables<br />
are at the core <strong>of</strong> Medica manufactur<strong>in</strong>g. S<strong>in</strong>ce<br />
the early 90’s Medica cont<strong>in</strong>ues to work on develop<strong>in</strong>g<br />
and manufactur<strong>in</strong>g <strong>of</strong> hollow fiber membranes for<br />
both medical and water purification applications. The<br />
development and manufactur<strong>in</strong>g <strong>of</strong> these technologies<br />
is primarily <strong>in</strong> house. www.medica.it<br />
Medikit ............................................................. Booth 1.35<br />
Medikit is a lead<strong>in</strong>g manufacturer <strong>of</strong> vascular access<br />
medical devices based <strong>in</strong> Tokyo, Japan. Supercath<br />
brand hemodialysis fistula catheter, upgrade replacement<br />
<strong>of</strong> steel fistula needle, can reduce risk <strong>of</strong> damage<br />
with cannulation on AV fistulas and AV Grafts. Catheters<br />
with safety mechanism prevent<strong>in</strong>g accidental<br />
needle-stick <strong>in</strong>juries are also available. Come and visit<br />
us at stand 1.35. www.medikit.co.jp<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
417<br />
EXHIBITORS
EXHIBITORS<br />
418<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Meditechlab & Suisse Med Technologies .... Booth 1.91<br />
Suisse Med Technologies is a market leader <strong>in</strong> provid<strong>in</strong>g<br />
synthetic hollow fiber sp<strong>in</strong>n<strong>in</strong>g l<strong>in</strong>es and dialyser<br />
assembly l<strong>in</strong>es. Our technology is designed to deliver<br />
optimal cost <strong>of</strong> goods while ensur<strong>in</strong>g worldwide quality<br />
standards. We support our customers achieve their<br />
f<strong>in</strong>ancial goals by <strong>of</strong>fer<strong>in</strong>g a wide range <strong>of</strong> additional<br />
services such as go-to-market strategies, regulatory<br />
compliance, ISO-10993 compliant devices and qualified<br />
raw materials. Our subsidiary, Meditechlab, is a<br />
supplier <strong>of</strong> quality dialysis products that meet all <strong>in</strong>ternational<br />
norms: ISO 9001 v-2000, ISO 13485 v-2003<br />
and the European Medical Device Directive 93/42/<br />
EEC (CE-mark).<br />
www.meditechlab.com www.SuisseMT.com<br />
MediTheque Bookshop ................................Booth 1.P5<br />
Medvision ...................................................... Booth 1.115<br />
As an <strong>in</strong>ternational developer <strong>of</strong> pr<strong>of</strong>essional medical<br />
<strong>in</strong>formation systems, we are provid<strong>in</strong>g efficient and<br />
economical solutions for the treatment and care <strong>of</strong> sick<br />
people for over twenty years now. Our medical <strong>in</strong>formation<br />
systems are used <strong>in</strong> many doctor’s practices,<br />
outpatient cl<strong>in</strong>ics, hospitals, dialysis units, and medical<br />
care centres. Especially <strong>in</strong> the field <strong>of</strong> dialysis, we<br />
have made a name for ourselves with a market share<br />
<strong>of</strong> well over 60 % <strong>in</strong> Germany and a large number <strong>of</strong><br />
customers <strong>in</strong> Europe and Asia. Our <strong>in</strong>ternational OEM<br />
cooperation partners are the world leaders <strong>in</strong> dialysis.<br />
www.medvision.de<br />
MedXL ........................................................... Booth 1.G10<br />
MedXL designs and manufactures quality healthcare<br />
products s<strong>in</strong>ce 1992 and is a leader <strong>in</strong> sett<strong>in</strong>g the standards<br />
for safe, secure and efficacious prefilled syr<strong>in</strong>ge<br />
products. Our prefilled CitraFlow syr<strong>in</strong>ges conta<strong>in</strong><strong>in</strong>g<br />
4% sodium citrate are currently used <strong>in</strong> many<br />
countries as an alternative to hepar<strong>in</strong> for lock<strong>in</strong>g catheters.<br />
CitraFlow is a natural way to safely and effectively<br />
lock <strong>in</strong>dwell<strong>in</strong>g catheters. www.medxl.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Membrana........................................................ Booth 2.20<br />
Membrana is the largest <strong>in</strong>dependent membrane producer<br />
worldwide. Membrana is part <strong>of</strong> Polypore International<br />
Inc., a global high technology company<br />
specializ<strong>in</strong>g <strong>in</strong> microporous membranes. Membrana<br />
<strong>of</strong>fers a wide range <strong>of</strong> capillary and flat sheet membranes,<br />
particularly for haemodialysis, blood oxygenation<br />
and plasmapheresis. Products <strong>in</strong>clude the<br />
haemodialysis membrane families <strong>of</strong> DIAPES ® and<br />
PUREMA ® . Membrana also manufactures a variety<br />
<strong>of</strong> membranes used for filtration <strong>in</strong> various <strong>in</strong>dustries<br />
and applications and the Liqui-Cel ® contact<strong>ors</strong> for gas<br />
transfer as well as the Liqui-Flux ® modules for membrane<br />
filtration. www.membrana.com<br />
Miltenyi Biotec ............................................... Booth 2.40<br />
Miltenyi Biotec, a diversified biotechnology and medical<br />
device company, <strong>of</strong>fers the Cl<strong>in</strong>iMACS ® Cell Selection<br />
System. Based on MACS ® Technology, it can be<br />
used for cl<strong>in</strong>ical-scale magnetic enrichment <strong>of</strong> cells.<br />
Another exemplary cl<strong>in</strong>ical application represents TheraSorb<br />
Therapeutic Apheresis, which selectively<br />
removes pathogenic substances from the blood by immunoadsorption.<br />
www.miltenyibiotec.com<br />
Mitsubishi Pharma Europe .......................... Booth 1.10<br />
Mitsubishi Pharma Europe is the European Headquarters<br />
<strong>of</strong> one <strong>of</strong> Japan’s largest pharmaceutical companies,<br />
Mitsubishi Tanabe Pharma Corporation. Based <strong>in</strong><br />
London, Mitsubishi Pharma Europe is engaged <strong>in</strong> the<br />
cl<strong>in</strong>ical development <strong>of</strong> new drugs for the European<br />
markets. Mitsubishi Pharma Europe is conduct<strong>in</strong>g trials<br />
<strong>in</strong> Europe <strong>in</strong> the follow<strong>in</strong>g therapy areas; cardiovascular,<br />
diabetes, CNS and renal conditions. The staff<br />
<strong>in</strong>clude regulatory, QA, cl<strong>in</strong>ical, biostatistics, medical<br />
<strong>in</strong>formation, pharmacovigilance, pharmaceutical technology<br />
and market<strong>in</strong>g. www.mitsubishi-pharma.eu<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
419<br />
EXHIBITORS
EXHIBITORS<br />
420<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Nature Publish<strong>in</strong>g Group .............................Booth 1.P2<br />
Nature Publish<strong>in</strong>g Group (NPG) br<strong>in</strong>gs you lead<strong>in</strong>g<br />
scientific and medical research. Our portfolio comb<strong>in</strong>es<br />
the cont<strong>in</strong>ued excellence <strong>of</strong> Nature, its associated<br />
research and review journals, and over 50 lead<strong>in</strong>g<br />
academic and society journals <strong>in</strong> the life, physical<br />
and cl<strong>in</strong>ical sciences. Open access options are <strong>of</strong>fered<br />
through the academic and society journals. NPG also<br />
provides timely news content and, through Naturejobs,<br />
scientific career <strong>in</strong>formation. Visit the NPG stand<br />
P02 to pick up your free sample copies <strong>of</strong> Kidney International,<br />
Nature Reviews Nephrology and other<br />
NPG journals, subscribe at the conference rate, or f<strong>in</strong>d<br />
out about advertis<strong>in</strong>g opportunities <strong>in</strong> any NPG title.<br />
www.nature.pg<br />
NDT-ERBP-NDT-Educational ................... Booth 1.102<br />
Visit the <strong>ERA</strong>-<strong>EDTA</strong> booth to f<strong>in</strong>d <strong>in</strong>formation about<br />
the current activities, especially with regard to educational<br />
<strong>in</strong>itiatives and to the European Renal Best Practice.<br />
ERBP’s ma<strong>in</strong> purpose is to help <strong>in</strong>creas<strong>in</strong>g the<br />
implementation <strong>of</strong> European nephrology recommendations<br />
and guidance and to enhance the quality <strong>of</strong><br />
European and worldwide nephrology practice. ERBP<br />
has also created a set <strong>of</strong> patient <strong>in</strong>formation documents,<br />
<strong>in</strong> the belief that jo<strong>in</strong>t decisions, made together<br />
by physicians and well-<strong>in</strong>formed patients, are fundamental<br />
to obta<strong>in</strong> the best treatment for each <strong>in</strong>dividual<br />
renal patient.<br />
At the booth you can also collect a pr<strong>in</strong>ted copy <strong>of</strong> this<br />
congress’s Book <strong>of</strong> Abstracts, if you wish to have a paper<br />
version <strong>of</strong> it <strong>in</strong> addition to the one on CD.<br />
www.eraedta.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Nephrokit ........................................................ Booth 1.28<br />
Nephtrokit was founded on December 2007, by Dr<br />
Mokhtar Chawki, skilled French Nephrologist on dialysis<br />
vascular access field. Based on the west suburb <strong>of</strong><br />
Paris. Nephrokit is an <strong>in</strong>novative start-up who deta<strong>in</strong>s<br />
4 validated patents for improv<strong>in</strong>g techniques <strong>of</strong> secur<strong>in</strong>g<br />
dialysis needle and reduc<strong>in</strong>g post dialysis time to<br />
clot <strong>of</strong> vascular access puncture sites. Nephrokit creates<br />
a breakthrough with new compressive device<br />
named “IRIS” ® for dialysis access puncture sites. Non<br />
exclusive agreement for IRIS distribution was signed<br />
with Bellco France and Belgium, Gambro France. The<br />
device is also sold <strong>in</strong> dialysis kits by Mölnylcke <strong>in</strong> Europe.<br />
Nephrokit is also seek<strong>in</strong>g to <strong>in</strong>troduce Iris ® <strong>in</strong> the doma<strong>in</strong><br />
<strong>of</strong> blood transfusion and is look<strong>in</strong>g for partners<br />
<strong>in</strong> this field. www.nephrokit.com<br />
Nikkiso Europe .............................................. Booth 2.75<br />
The Nikkiso group has been provid<strong>in</strong>g technologies<br />
and products <strong>in</strong> order to meet demands <strong>of</strong> our customer,<br />
the society and the times we live <strong>in</strong> for more<br />
than half a century. The Nikkiso Europe GmbH is our<br />
European entity based <strong>in</strong> Hanover/Germany and responsible<br />
for production and distribution <strong>of</strong> our excellent<br />
technologies to the EMEA (Europe, Middle East,<br />
Africa) region. Beyond production and distribution<br />
Nikkiso Europe is able to develop extracorporeal technologies<br />
<strong>in</strong> our Research and Development department.<br />
Overall the Nikkiso Europe GmbH is our clear<br />
commitment to Europe and our customers there. Nikkiso<br />
Europe GmbH – Our flexibility is your efficiency.<br />
www.nikkiso-europe.eu<br />
TYH<br />
R<br />
N<strong>in</strong>gbo Tianyi Medical Appliance .......... Booth 1.G15<br />
Established <strong>in</strong> 1998, N<strong>in</strong>gbo Tianyi Medical is specialized<br />
<strong>in</strong> produc<strong>in</strong>g hemodialysis blood l<strong>in</strong>e, blood<br />
tub<strong>in</strong>g sets for Cont<strong>in</strong>uous Renal Replacement Treatment<br />
(CRRT), Arterial venous fistula (AVF) needle,<br />
<strong>in</strong>fusion set, blood transfusion set ect. The company<br />
has achieved ISO 13485 certification. Products are under<br />
CE and CCC certificates. “Quality first, scientific<br />
management, s<strong>in</strong>cere and creditable service, customeroriented”<br />
is our bus<strong>in</strong>ess concept. www.tiany<strong>in</strong>b.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
421<br />
EXHIBITORS
EXHIBITORS<br />
422<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Nipro Europe................................................... Booth 2.14<br />
Nipro Europe has built its reputation on consistent<br />
high levels <strong>of</strong> quality and service <strong>in</strong> Europe. With its<br />
5 Bus<strong>in</strong>ess Units, we distribute products for hemodialysis<br />
(Renal Care), hospital consumables (Hospital<br />
Products), blood glucose diagnostics (Diabetes Care),<br />
oxygenat<strong>ors</strong> and accessories (Cardiopulmonary) and<br />
medical glass products (Pharmaceutical Solutions).<br />
Our priority is build<strong>in</strong>g long-term partnerships with<br />
each customer. This is accomplished by provid<strong>in</strong>g superior<br />
quality and value throughout the bus<strong>in</strong>ess <strong>in</strong><br />
addition to <strong>list</strong>en<strong>in</strong>g to customer needs and translat<strong>in</strong>g<br />
those needs <strong>in</strong>to specific products and services. We<br />
constantly thrive to create and <strong>of</strong>fer safe, high-quality<br />
products ensur<strong>in</strong>g a better quality <strong>of</strong> life.<br />
www.nipro-europe.com<br />
NKF USA ......................................................... Booth 2.26<br />
NKF USA <strong>of</strong>fers the nephrology community the latest<br />
science and practical tools through our cl<strong>in</strong>ical practice<br />
guidel<strong>in</strong>es, our free kidney screen<strong>in</strong>g programs,<br />
and our pr<strong>of</strong>essional memberships. Learn more about<br />
KDOQI (T), KEEP (T), and our scientific journals:<br />
AJKD, ACKD and JRN. F<strong>in</strong>d out about the new KDI-<br />
GO (R) Guidel<strong>in</strong>es that are be<strong>in</strong>g published this year<br />
<strong>in</strong>clud<strong>in</strong>g AKI, GN, Hypertension and Anemia.<br />
www.kidney.org<br />
Novartis Pharmaceuticals - Oncology ........ Booth 1.31<br />
Novartis is a global leader <strong>in</strong> oncology through strong<br />
research and development efforts and a broad portfolio<br />
<strong>of</strong> marketed products. Novartis Oncology discovers<br />
and develops <strong>in</strong>novative therapies <strong>in</strong>clud<strong>in</strong>g Glivec ®<br />
(imat<strong>in</strong>ib), Tasigna ® (nilot<strong>in</strong>ib), Af<strong>in</strong>itor ® (everolimus),<br />
Zometa ® (zoledronic acid), Femara ® (letrozole), Sandostat<strong>in</strong><br />
® LAR ® (octreotide acetate for <strong>in</strong>jectable suspension)<br />
and Exjade ® (deferasirox). Novartis Oncology<br />
has one <strong>of</strong> the broadest and most comprehensive<br />
pipel<strong>in</strong>es <strong>in</strong> the <strong>in</strong>dustry, currently with more than<br />
20 novel medic<strong>in</strong>es <strong>in</strong> development that target many<br />
therapeutically important prote<strong>in</strong>s to help address the<br />
unmet needs <strong>of</strong> patients. www.novartis.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
NxStage Medical ............................................ Booth 1.02<br />
NxStage is lead<strong>in</strong>g a movement to transform renal<br />
care. To make it simpler. To make it portable. To expand<br />
treatment options for cl<strong>in</strong>icians by overcom<strong>in</strong>g<br />
traditional barriers. NxStage is f<strong>in</strong>d<strong>in</strong>g itself at the<br />
forefront <strong>of</strong> dramatically improved renal care, thanks<br />
to <strong>in</strong>novative yet simple therapeutic solutions that<br />
benefit patients, caregivers, and society. For more <strong>in</strong>formation<br />
visit www.nxstage.com<br />
Otsuka Pharmaceuticals Europe ................. Booth 1.60<br />
Otsuka Pharmaceutical is a global healthcare company<br />
with the corporate philosophy: ‘Otsuka-people<br />
creat<strong>in</strong>g new products for better health worldwide.’<br />
The Otsuka Group is comprised <strong>of</strong> 151 companies and<br />
employs approximately 40,000 people <strong>in</strong> 23 countries<br />
and regions worldwide. Otsuka is committed to focus<strong>in</strong>g<br />
its research and development on <strong>in</strong>novative products<br />
and medical devices that address unmet medical<br />
needs, particularly <strong>in</strong> our specia<strong>list</strong> areas <strong>of</strong> renal, endocr<strong>in</strong>e,<br />
gastro-<strong>in</strong>test<strong>in</strong>al and central nervous system<br />
disorders. Come and visit Otsuka Europe at Stand 1.60<br />
on Level 1 at the Palais des Congrès de Paris, to learn<br />
more about Otsuka’s commitment to <strong>in</strong>novation and<br />
education <strong>in</strong> nephrology. www.otsuka-europe.com<br />
OUP Oxford University Press ...................... Booth 1.72<br />
Oxford University Press publishes some <strong>of</strong> most respected<br />
medical books and journals <strong>in</strong> the world <strong>in</strong>clud<strong>in</strong>g<br />
the Oxford Cl<strong>in</strong>ical Nephrology Series, and on<br />
behalf <strong>of</strong> the <strong>ERA</strong>-<strong>EDTA</strong> we publish the lead<strong>in</strong>g European<br />
journal Nephrology Dialysis Transplantation as<br />
well as CKJ (Cl<strong>in</strong>ical Kidney Journal). Visit our stand<br />
to browse books and to pick up free copies <strong>of</strong> the journals.<br />
www.oxfordjournals.org and www.oup.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
423<br />
EXHIBITORS
EXHIBITORS<br />
424<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
PakuMed .......................................................... Booth 1.36<br />
PakuMed medical products gmbh is a German company<br />
founded <strong>in</strong> 1990 specialized <strong>in</strong> the development,<br />
manufacture and worldwide distribution <strong>of</strong> special<br />
medical products. Highly qualified medical competence,<br />
flexibility and close cooperation with our customers<br />
as well as best service are our strong po<strong>in</strong>ts.<br />
Our product quality meets highest <strong>in</strong>ternational standard<br />
with reasonable prices. Besides port catheter systems<br />
and accessories, <strong>in</strong>novative products for Hemodialysis<br />
and Apheresis are designed to meet the needs<br />
<strong>of</strong> our clients and complete our product range.<br />
www.pakumed.de<br />
Pharmacosmos ................................................ Booth 2.13<br />
PHARMACOSMOS develops and markets medic<strong>in</strong>es<br />
for the treatment <strong>of</strong> iron deficiency. An <strong>in</strong>dependent<br />
pharmaceutical company with an ongo<strong>in</strong>g R&D programme,<br />
Pharmacosmos’ goal is to improve treatment<br />
options for healthcare pr<strong>of</strong>essionals and patients,<br />
by <strong>of</strong>fer<strong>in</strong>g <strong>in</strong>novative treatments - Pharmacosmos<br />
works with exclusive partners <strong>in</strong> more than 50 countries<br />
worldwide. Pharmacosmos holds the market<strong>in</strong>g<br />
authorisation for Mon<strong>of</strong>er ® (iron isomaltoside 1000),<br />
a treatment for iron deficiency anaemia that <strong>of</strong>fers<br />
patients with various iron needs the convenience <strong>of</strong><br />
high dose iron <strong>in</strong> one visit. Seventy million doses <strong>of</strong><br />
its second parenteral iron preparation CosmoFer ® (low<br />
molecular weight iron dextran) have already been adm<strong>in</strong>istered<br />
worldwide. www.pharmacosmos.com<br />
Physidia ............................................................ Booth 1.65<br />
Physidia is a French start-up. Its mission is the development<br />
and market<strong>in</strong>g <strong>of</strong> a daily hemodialysis system<br />
suitable for home use. The project was <strong>in</strong>itiated <strong>in</strong><br />
Lyon. In 2002-2005, the first tests systems were developed,<br />
which passed cl<strong>in</strong>ical trials. The S³ system will<br />
be marketed <strong>in</strong> 2013 <strong>in</strong> France. Ma<strong>in</strong> features are: premix<br />
dialysate; disposable l<strong>in</strong>es and pumps; simplified<br />
operations; truly portable; versatile modalities: SDHD<br />
and HDF, practice <strong>in</strong>spired by peritoneal dialysis.<br />
www.physidia.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
PosterSessionOnL<strong>in</strong>e -<br />
Poster Virtual Gallery ................................... Booth 1.24<br />
PosterSessionOnl<strong>in</strong>e is the world’s largest free-access<br />
medical poster resource - browse posters from <strong>ERA</strong>-<br />
<strong>EDTA</strong> and more than 50 other congresses onl<strong>in</strong>e at<br />
your leisure. Log on to the excit<strong>in</strong>g new <strong>ERA</strong>-<strong>EDTA</strong><br />
ONLINE POSTER FORUM to ask questions to the presenters,<br />
exchange ideas and network with colleagues.<br />
PosterSessionOnl<strong>in</strong>e has also provided all poster presenters<br />
with the opportunity to have their posters<br />
pr<strong>in</strong>ted and delivered free <strong>of</strong> charge to the congress<br />
venue, pick<strong>in</strong>g them up from the Takeda Hospitality<br />
Suite dur<strong>in</strong>g the meet<strong>in</strong>g.<br />
Log <strong>in</strong> and jo<strong>in</strong> the debate <strong>in</strong> the Era-Edta onl<strong>in</strong>e poster<br />
forum! www.postersessiononl<strong>in</strong>e.com<br />
Pronefro............................................................ Booth 1.96<br />
Pronefro, Produtos Nefrológicos, S.A. company was<br />
founded <strong>in</strong> 1983 and has its headquarters <strong>in</strong> Maia,<br />
located around 10km Porto <strong>in</strong> north <strong>of</strong> Portugal. We<br />
have a large experience has manufacture s<strong>in</strong>ce we<br />
have been work<strong>in</strong>g with medical devices and more<br />
specifically on dialysis products for over 25 years. We<br />
have <strong>in</strong> our range <strong>of</strong> products, bloodl<strong>in</strong>es, AV fistulas<br />
needles, dialysers, catheters, therapy chairs, tubes for<br />
esthetical use, diabetics shoes and others accessories.<br />
We work mostly with distribut<strong>ors</strong>, our product quality<br />
meets highest <strong>in</strong>ternational standards; the company is<br />
certified accord<strong>in</strong>g to EN ISO 9001 and EN ISO 13845.<br />
For more <strong>in</strong>formation please see our website<br />
www.pronefro.pt<br />
Roche ................................................................ Booth 2.52<br />
Headquartered <strong>in</strong> Basel, Switzerland, Roche is a<br />
leader <strong>in</strong> research-focused healthcare with comb<strong>in</strong>ed<br />
strengths <strong>in</strong> pharmaceuticals and diagnostics. Roche<br />
is the world’s largest biotech company with truly differentiated<br />
medic<strong>in</strong>es <strong>in</strong> oncology, virology, <strong>in</strong>flammation,<br />
metabolism and CNS. Roche is also the world<br />
leader <strong>in</strong> <strong>in</strong>-vitro diagnostics, tissue-based cancer<br />
diagnostics and a pioneer <strong>in</strong> diabetes management.<br />
Roche’s personalized healthcare strategy aims at provid<strong>in</strong>g<br />
medic<strong>in</strong>es and diagnostic tools that enable tangible<br />
improvements <strong>in</strong> the health, quality <strong>of</strong> life and<br />
survival <strong>of</strong> patients. For more <strong>in</strong>formation:<br />
www.roche.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
425<br />
EXHIBITORS
EXHIBITORS<br />
426<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Sandoz .............................................................. Booth 2.73<br />
Sandoz is a Novartis company with a reputation for<br />
quality go<strong>in</strong>g back to the 19 th century. Present <strong>in</strong> 130<br />
countries, our broad portfolio <strong>of</strong> affordable, high-quality<br />
medic<strong>in</strong>es is available to 90% <strong>of</strong> the world’s population.<br />
Sandoz Biopharmaceuticals, a specialized bus<strong>in</strong>ess<br />
with<strong>in</strong> Sandoz and Novartis, develops, produces<br />
and markets biopharmaceutical medic<strong>in</strong>es and active<br />
<strong>in</strong>gredients worldwide, and enjoys close synergies<br />
across the value cha<strong>in</strong> with other parts <strong>of</strong> the Novartis<br />
Group. Our decades <strong>of</strong> experience and significant<br />
<strong>in</strong>vestments have helped to position us as the pioneer<br />
and global leader <strong>in</strong> biosimilars. Our vision is to<br />
dramatically <strong>in</strong>crease patient access to essential highquality<br />
biopharmaceuticals, by consistently advanc<strong>in</strong>g<br />
this global leadership position. www.sandoz.com<br />
San<strong>of</strong>i Aventis Groupe .................................. Booth 2.79<br />
San<strong>of</strong>i a diversified global healthcare leader, focused<br />
on patients’ needs<br />
San<strong>of</strong>i has core strengths <strong>in</strong> the field <strong>of</strong> healthcare<br />
with growth platforms: emerg<strong>in</strong>g markets, human<br />
vacc<strong>in</strong>es, consumer healthcare, diabetes, <strong>in</strong>novative<br />
products and animal health. Through the acquisition<br />
<strong>of</strong> Genzyme, San<strong>of</strong>i has re<strong>in</strong>forced its footpr<strong>in</strong>t <strong>in</strong> biotechnology<br />
and rare diseases.<br />
San<strong>of</strong>i’ strategy is based on three key pr<strong>in</strong>ciples <strong>in</strong> order<br />
to deliver long-term susta<strong>in</strong>able growth: <strong>in</strong>creas<strong>in</strong>g<br />
<strong>in</strong>novation <strong>in</strong> Research & Development, seiz<strong>in</strong>g<br />
external growth opportunities, adapt to future challenges<br />
and opportunities.<br />
San<strong>of</strong>i:<br />
- More than 110,000 employees <strong>in</strong> 100 countries<br />
- 2011 net sales: €33.4 billion<br />
For more <strong>in</strong>formation: http://en.san<strong>of</strong>i.com/home.asp<br />
Savient Pharmaceuticals ............................... Booth 1.23<br />
Savient Pharma Ireland Limited, a wholly-owned subsidiary<br />
<strong>of</strong> Savient Pharmaceuticals, is a specialty biopharmaceutical<br />
company seek<strong>in</strong>g regulatory approval<br />
for KRYSTEXXA ® <strong>in</strong> the European Union for the treatment<br />
<strong>of</strong> refractory chronic gout. KRYSTEXXA is available<br />
<strong>in</strong> the European Union through a Named Patient<br />
Programme and is currently the only FDA approved<br />
product for this <strong>in</strong>dication <strong>in</strong> the United States.<br />
www.savient.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
Serumwerk Bernburg .................................... Booth 1.61<br />
The Serumwerk Bernburg Group is an <strong>in</strong>ternationally<br />
- renowned producer and supplier <strong>of</strong> medic<strong>in</strong>al<br />
products and medical devices for human and veter<strong>in</strong>ary<br />
use, based <strong>in</strong> Germany. The dialysis division is<br />
successfully active s<strong>in</strong>ce 1998 <strong>in</strong> Europe, Middle East,<br />
Asia and North Africa. It <strong>of</strong>fers a wide range <strong>of</strong> medical<br />
disposables for hemodialysis, e.g. VitaPES dialyzers,<br />
DiaCart & DiaBox bicarbonate cartridges, bloodl<strong>in</strong>es<br />
and IV solutions. The company is focused on<br />
<strong>of</strong>fer<strong>in</strong>g “Made <strong>in</strong> Germany” products to their worldwide<br />
clients. www.serumwerk.de<br />
Shire Pharmaceuticals ................................... Booth 2.01<br />
Shire shares the vision <strong>of</strong> nephrology practitioners to<br />
place the best <strong>in</strong>terest <strong>of</strong> patients at the heart <strong>of</strong> everyth<strong>in</strong>g<br />
we do. The commitment <strong>of</strong> Shire is to enable<br />
people with life-alter<strong>in</strong>g conditions to lead better lives.<br />
In the field <strong>of</strong> nephrology, Shire supports research<br />
which improves understand<strong>in</strong>g <strong>of</strong> renal science, kidney<br />
health awareness and education <strong>in</strong> renal units<br />
Products <strong>in</strong>clude Fosrenol ® , a non-calcium, non-res<strong>in</strong><br />
phosphate b<strong>in</strong>der for the management <strong>of</strong> hyperphosphataemia.<br />
www.shire.com<br />
S<strong>in</strong>ed ................................................................. Booth 1.57<br />
S<strong>in</strong>ed is an <strong>in</strong>ternational medical computer solutions<br />
specia<strong>list</strong>, focused exclusively on the design, manufacture,<br />
<strong>in</strong>stallation and ma<strong>in</strong>tenance <strong>of</strong> remote monitor<strong>in</strong>g,<br />
cl<strong>in</strong>ical record and data collection systems. S<strong>in</strong>ed<br />
not only <strong>of</strong>fers lead<strong>in</strong>g expertise as a pioneer <strong>of</strong> IT <strong>in</strong><br />
nephrology, but is uniquely customer focused, committed<br />
to multi-brand compatibility that protects exist<strong>in</strong>g<br />
<strong>in</strong>vestments while provid<strong>in</strong>g fully-customised, scalable<br />
solutions that meet all a customer’s needs cost-effectively.<br />
Renowned for close customer service, S<strong>in</strong>ed works<br />
with medical, IT and adm<strong>in</strong>istrative staff to <strong>in</strong>crease<br />
efficiency and reduce risks, simultaneously improv<strong>in</strong>g<br />
stock and f<strong>in</strong>ance management to achieve substantial<br />
sav<strong>in</strong>gs and reliable revenue. www.s<strong>in</strong>ed.it<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
427<br />
EXHIBITORS
EXHIBITORS<br />
428<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Soludia Maghreb ............................................ Booth 2.65<br />
Based <strong>in</strong> Morocco s<strong>in</strong>ce 1998, Soludia Maghreb pharmaceutical<br />
laboratory is the lead<strong>in</strong>g manufacturer<br />
specialized <strong>in</strong> produc<strong>in</strong>g haemodialysis solution and<br />
powder products with a French licence. We provide<br />
excellent service to our customers. Our company is<br />
certified ISO 9001, ISO 13485, CE 120 labelled products,<br />
ISO 17025 <strong>in</strong> progress<br />
Our range <strong>of</strong> products :<br />
- Bicarbonate liquid, Bicarbonate powder for Gambro<br />
generator, for Fresenius generator and for Bellco generator.<br />
- 5 liters acid bag, acetate free acid, acid central with<br />
1000 liters Tank.<br />
- water analysis for haemodialysis<br />
We have the big part <strong>of</strong> the Moroccan market shares.<br />
We have been export<strong>in</strong>g our products to West Africa.<br />
We started export<strong>in</strong>g our products to Europe.<br />
For additional <strong>in</strong>formation on our company and products,<br />
please log on our website www.soludia.ma<br />
Takeda Pharmaceuticals Europe ......... Booth P01+P02<br />
Takeda is a research-based global pharmaceutical<br />
company committed to striv<strong>in</strong>g towards better health<br />
for patients worldwide through lead<strong>in</strong>g <strong>in</strong>novations<br />
<strong>in</strong> medic<strong>in</strong>e. Takeda is renowned for its expertise and<br />
is dedicated to build<strong>in</strong>g on its success as a leader and<br />
preferred partner <strong>in</strong> the pharmaceutical <strong>in</strong>dustry.<br />
Takeda’s vision is to embody worldwide pharmaceutical<br />
leadership through <strong>in</strong>novation, culture and growth,<br />
guided by an unwaver<strong>in</strong>g commitment to significantly<br />
improve the lives <strong>of</strong> patients. www.takeda.eu<br />
TauroPharm ..................................................... Booth 1.43<br />
TauroPharm GmbH is a life science company specialized<br />
<strong>in</strong> antimicrobial medical devices. One <strong>of</strong> the<br />
company’s core <strong>in</strong>terests is to <strong>of</strong>fer a safe and effective<br />
technology for lock<strong>in</strong>g central venous access devices<br />
(catheters and ports). TauroLock, a non-antibiotic<br />
lock solution, which is capable <strong>of</strong> dramatically reduc<strong>in</strong>g<br />
catheter related blood stream <strong>in</strong>fections (CRBSI) is<br />
free <strong>of</strong> side effects. TauroLock is highly effective <strong>in</strong><br />
eradicat<strong>in</strong>g bacteria and fungi and has been successfully<br />
tested on more than five hundred organisms, <strong>in</strong>clud<strong>in</strong>g<br />
multiresistant forms such as MRSA and VRE.<br />
It is to be used <strong>in</strong> dialysis, oncology, <strong>in</strong>tensive care and<br />
parenteral nutrition. To improve catheter patency Tau-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
roLock products conta<strong>in</strong> 4% citrate and/or hepar<strong>in</strong><br />
(TauroLock, TauroLock-Hep100, TauroLock-<br />
Hep500) and/or urok<strong>in</strong>ase (TauroLock-U25.000).<br />
www.tauropharm.de<br />
Terumo BCT ..................................................Booth 1.98B<br />
CaridianBCT and Terumo Transfusion have united to<br />
become Terumo BCT, a global leader <strong>in</strong> blood component<br />
and cellular technologies. We believe <strong>in</strong> the potential<br />
<strong>of</strong> blood and cell therapies to do even more for<br />
the world than they do today. As we strive to make<br />
even safer, higher-quality transfusions available, we<br />
can help our customers br<strong>in</strong>g even more treatment options<br />
to patients with advanced blood therapies and<br />
we can help researchers develop cell therapies that<br />
may fundamentally improve health care.<br />
www.terumobct.com<br />
BRAHMS GmbH,<br />
Part <strong>of</strong> Thermo Fisher Scientific ................ Booth 1.113<br />
Thermo Fisher Scientific specialises <strong>in</strong> <strong>in</strong>novative<br />
products that facilitate earlier diagnosis <strong>of</strong> diseases<br />
and better control <strong>of</strong> therapy, thus enabl<strong>in</strong>g doct<strong>ors</strong> to<br />
provide more efficient and economic patient care.<br />
Major fields <strong>of</strong> activity are diagnosis <strong>of</strong> <strong>in</strong>fectious and<br />
thyroid diseases, cardiology and pneumology as well<br />
as sepsis, tum<strong>ors</strong>, and Down’s syndrome.<br />
www.thermoscientific.com/brahms<br />
Tianj<strong>in</strong> Denny Tech Co. ..............................Booth 1.63B<br />
We are pr<strong>of</strong>essional manufacturer <strong>of</strong> dialysis product,<br />
We hold 1000 m2 clean room and completed foundation<br />
complementation. We possess advanced <strong>in</strong>jection<br />
mach<strong>in</strong>e, extrud<strong>in</strong>g mach<strong>in</strong>e, high frequency heat<br />
seal<strong>in</strong>g mach<strong>in</strong>e, ETO sterilization equipment, semiproduct<br />
automatic assembl<strong>in</strong>g mach<strong>in</strong>e, large-scale<br />
central air condition<strong>in</strong>g system and cool<strong>in</strong>g unit. The<br />
composition delivers the totally enclosed production<br />
process from raw material <strong>in</strong>vestment to the end product.The<br />
blood tub<strong>in</strong>g and arterial venous fistula needle<br />
was sales <strong>in</strong> world wide and we have passed CE and<br />
ISO13485 quality certification.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
429<br />
EXHIBITORS
EXHIBITORS<br />
430<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Toray ................................................................ Booth 1.49<br />
Toray is a lead<strong>in</strong>g manufacturer <strong>of</strong> synthetic fibers and<br />
dedicated to the development <strong>of</strong> dialysis products under<br />
its corporate slogan, “Innovation by Chemistry”.<br />
Toray supports high quality and advanced medical<br />
care with our biocompatible polymethylmethacrylate<br />
dialyzer, FILTRYZER, high flux polysulfone dialyzer,<br />
TORAYSULFONE & TORAYLIGHT, and dialysis mach<strong>in</strong>e,<br />
TR-8000.<br />
www.toray-medical.com/en/<strong>in</strong>dex.html<br />
Turkish Society <strong>of</strong> Nephrology ................ Booth 1.G12<br />
When the Turkish Society <strong>of</strong> Nephrology (TSN) was<br />
founded <strong>in</strong> Istanbul forty one years ago <strong>in</strong> 1970, it co<strong>in</strong>cided<br />
with that <strong>of</strong> many <strong>of</strong> the Western European<br />
Nephrology Societies. Currently, TSN has 411 active<br />
members and 11 work<strong>in</strong>g groups also 8 branches with<br />
their own separate memberships <strong>in</strong> Istanbul, Izmir,<br />
Kayseri, Antalya, Bursa, Konya, Adana and Ankara.<br />
Turkish membership has actually reached 273 <strong>in</strong> ISN<br />
& 294 <strong>in</strong> <strong>ERA</strong>-<strong>EDTA</strong> (6th largest membership). TSN<br />
has <strong>in</strong>creased its patient awareness activities this year<br />
and on the Kidney Day, TSN Activities consisted <strong>of</strong><br />
a large variety from Banners <strong>in</strong> Football Matches to<br />
Newspaper Advertisements, TV Ads, Stands <strong>in</strong> Shopp<strong>in</strong>g<br />
Malls, Press Brief<strong>in</strong>gs School Visits and handouts<br />
<strong>in</strong> Nephrology Centers. www.tsn.org.tr/en/<br />
Vifor Fresenius Medical Care<br />
Renal Pharma .........................................Booth 2.22+2.23<br />
Vifor Fresenius Medical Care Renal Pharma Ltd. is a<br />
strategic partnership between Vifor Pharma and Fresenius<br />
Medical Care. The nephrology company develops<br />
and commercialises <strong>in</strong>novative and high-quality<br />
products to improve the lives <strong>of</strong> patients suffer<strong>in</strong>g<br />
from chronic kidney disease worldwide. The products<br />
<strong>in</strong>clude Ven<strong>of</strong>er ® and Fer<strong>in</strong>ject ® <strong>in</strong> the field <strong>of</strong> dialysis<br />
and pre-dialysis (CKD stage III – V) as well as PA21, a<br />
novel iron-based phosphate b<strong>in</strong>der.<br />
www.viforpharma.com/en/About-Vifor/bus<strong>in</strong>esses.<br />
php<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, 2012 PARIS, France<br />
E X H I B I T O R S<br />
W I C H T I G E D I T O R E<br />
MEDICAL PUBLISHER<br />
Wichtig Editore ................................................Booth 1P3<br />
Wichtig Editore Medical publisher began its activity<br />
<strong>in</strong> 1977, dedicat<strong>in</strong>g passion and competence to the<br />
publication <strong>of</strong> widely appreciated scientific journals -<br />
focus<strong>in</strong>g on nephrology, dialysis and transplantation<br />
– mostly <strong>in</strong>dexed <strong>in</strong> important bibliographic databases.<br />
The Editorial Board <strong>of</strong> these outstand<strong>in</strong>g journals<br />
acknowledge well-known lead<strong>in</strong>g scientists and, it is<br />
also thanks to their contributions, that Wichtig Editore’s<br />
titles are <strong>in</strong>creas<strong>in</strong>gly appreciated worldwide.<br />
Also, to be up-to-date, Wichtig Editore Medical Publisher<br />
is work<strong>in</strong>g to make its publications available as<br />
e-pubs for tablets and smartphones<br />
Websites: www.artificial-organs.com - www.<br />
jnephrol.com - www.vascular-access.<strong>in</strong>fo - www.<br />
wichtig-publisher.com/g<strong>in</strong><br />
Wisepress ...................................................... Booth 1.G18<br />
Wisepress.com, Europe’s lead<strong>in</strong>g conference bookseller,<br />
has a complete range <strong>of</strong> relevant books and journals<br />
which can be purchased at the stand or, if you would<br />
rather not carry them, posted to you - Wisepress will<br />
deliver worldwide. We also have a comprehensive<br />
medical and scientific onl<strong>in</strong>e bookshop with great <strong>of</strong>fers.<br />
www.wisepress.com<br />
WS Far Ir Medical ....................................... Booth 1.63A<br />
We are the pioneer <strong>in</strong> Far-Infrared medical equipment<br />
<strong>in</strong>dustry, and have been manufactur<strong>in</strong>g the FIR Therapy<br />
Unit for 20 years; our product WS Far-Infrared<br />
Therapy Unit is an essential tool for vascular access<br />
care <strong>in</strong> the hemodialysis centers all across Taiwan. In<br />
March 2007, the cl<strong>in</strong>ical evidence, “Far Infrared Therapy:<br />
a Novel Treatment Improv<strong>in</strong>g Access Blood Flow<br />
and Unassisted Patency <strong>of</strong> Arteriovenous Fistula <strong>in</strong><br />
Hemodialysis Patients” was published <strong>in</strong> the Journal<br />
<strong>of</strong> American Society <strong>of</strong> Nephrology shows that Far-<br />
Infrared Therapy can effectively improve the access<br />
blood flow and unassisted patency <strong>of</strong> AV Fistula <strong>in</strong><br />
hemodialysis patients. www.far-<strong>in</strong>frared.com.tw<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
431<br />
EXHIBITORS